Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

C3_COLON_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C18
  • Hospital discharge: ICD-9 153
  • Hospital discharge: ICD-8 153
  • Cause of death: ICD-10 C18
  • Cause of death: ICD-9 153
  • Cause of death: ICD-8 153
  • Cancer registry: Topography ICD-O-3 C18
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

7967

4. Check minimum number of events

None

7967

5. Include endpoints

None

7967

6. Filter based on genotype QC (FinnGen only)

7967

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

List of similar endpoints to Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 7967 3581 4386
Unadjusted period prevalence (%) 1.61 1.22 1.93
Median age at first event (years) 69.20 67.95 70.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5491
Matched controls
54895
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
422
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
323.0
404
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
776.4
323.0
560
8
H02AB02
ATC
dexamethasone; systemic
90.7
323.0
1373
201
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
12280.6
323.0
1017
*
JFB30
NOMESCO Finland
Right hemicolectomy
175.9
323.0
1177
85
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.2
323.0
891
1020
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1784.2
323.0
888
6
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
323.0
347
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
396.8
323.0
1104
35
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
323.0
683
*
UJF32
NOMESCO Finland
Coloscopy
10.4
323.0
3658
8820
Z51.5
ICD-10 Finland
Palliative care
13.3
323.0
707
604
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
323.0
336
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
323.0
900
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
206.0
323.0
573
31
B01AB05
ATC
enoxaparin; parenteral
5.0
323.0
2896
9981
A04AA02
ATC
granisetron; systemic, transdermal
933.2
323.0
1236
17
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
323.0
558
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
323.0
380
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1766.4
323.0
471
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
750.2
323.0
543
8
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
323.0
768
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
567.2
323.0
322
6
WZC30
NOMESCO Finland
Teaching
6.6
323.0
1320
2514
WX302
NOMESCO Finland
Thoracal epidural anesthesy
34.0
323.0
1163
431
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
44.3
323.0
682
175
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
323.0
322
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
323.0
456
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
8322.6
323.0
735
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.1
323.0
2147
7387
JN4AD
NOMESCO Finland
Body CT examination
16.7
323.0
1094
803
TPH07
NOMESCO Finland
Cathetrisation of artery
5.4
323.0
1188
2679
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
7.5
323.0
1201
1984
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
323.0
543
*
JN4BD
NOMESCO Finland
Extensive body CT
22.4
323.0
1884
1251
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
8667.9
323.0
761
*
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
+∞
323.0
330
*
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
2532
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
26.5
323.0
714
308
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
323.0
1427
*
A03FA01
ATC
metoclopramide; systemic, rectal
13.4
323.0
2477
3177
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
323.0
314
*
L01BC06
ATC
capecitabine; oral
+∞
323.0
1884
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
8349.0
323.0
737
*
JN4CD
NOMESCO Finland
Very extensive body CT
16.4
323.0
542
364
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
323.0
2022
7583
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
323.0
1021
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
323.0
1421
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
355.0
323.0
452
14
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3712.4
323.0
677
*
JFB46
NOMESCO Finland
Resection of sigmoid colon
30.0
322.2
440
159
B01AB10
ATC
tinzaparin; parenteral
8.2
318.2
763
1060
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
+∞
312.4
297
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
310.3
295
*
A04AA01
ATC
ondansetron; systemic, rectal
14.7
304.2
530
396
D75
ICPC
Malignant neoplasm colon/rectum
345.0
296.0
297
9
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
295.4
281
*
JFB43
NOMESCO Finland
Left hemicolectomy
68.0
282.6
327
51
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
280.6
267
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
277.4
264
*
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
359.6
275.4
276
8
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.7
275.2
1055
2635
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
25.7
273.3
389
162
116
Kela drug reimbursment
Prostate cancer
+∞
273.1
260
*
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
+∞
268.9
256
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
266.8
254
*
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
+∞
261.5
249
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
1307.2
258.1
250
*
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
+∞
246.7
235
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
244.5
233
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
240.3
229
*
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
+∞
231.8
221
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.5
231.8
535
685
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2171.4
227.4
219
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.1
218.5
414
367
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
216.0
206
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.8
215.6
488
603
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.6
214.2
676
1336
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
130.8
211.0
226
18
115
Kela drug reimbursment
Breast cancer
+∞
209.7
200
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
58.9
209.6
248
44
ZX120
NOMESCO Finland
Intravenous
4.6
207.3
790
1919
N02AA05
ATC
oxycodone; systemic
3.5
206.4
1135
3822
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
+∞
204.4
195
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
203.3
194
*
A04AD12
ATC
aprepitant; systemic
1893.5
200.0
193
*
L03AA13
ATC
pegfilgrastim; parenteral
992.5
197.0
192
*
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
+∞
193.8
185
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
193.8
185
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
+∞
193.8
185
*
PJA12
NOMESCO Finland
Sentinel node biopsy
328.0
190.6
192
6
WX402
NOMESCO Finland
General anaesthesia
3.6
190.4
995
3198
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.2
189.8
803
2149
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
184.3
176
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
+∞
183.3
175
*
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
+∞
183.3
175
*
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
+∞
177.0
169
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
177.0
169
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
175.7
1017
3517
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
5.9
175.1
527
973
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
171.8
576
1208
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
+∞
170.6
163
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
575.1
170.1
168
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
1692.9
164.3
159
*
JAH00
NOMESCO Finland
Laparotomy
8.3
159.8
371
473
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
+∞
153.8
147
*
WF002
NOMESCO Finland
Radical radiotherapy
72.1
152.6
175
25
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
151.7
145
*
C18
ICD-10 Finland
Malignant neoplasm of colon
+∞
145.4
139
*
L03AA02
ATC
filgrastim; parenteral
66.5
144.8
168
26
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
143.3
137
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
142.4
1381
6514
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
142.4
636
1762
L02AE02
ATC
leuprorelin; implant, parenteral
46.2
141.9
175
39
8240/3-C18.2
ICD-O-3
Neuroendocrine tumor, NOS, of ascending colon
+∞
141.2
135
*
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
+∞
141.2
135
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.9
139.1
494
1094
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
1393.1
139.1
135
*
8240/3-C18.1
ICD-O-3
Neuroendocrine tumor, NOS, of appendix
+∞
138.0
132
*
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
47.0
137.5
169
37
JAL30
NOMESCO Finland
Omentectomy
44.3
135.1
168
39
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
100.6
133.7
147
15
WW500
NOMESCO Finland
Blood transfusion
7.3
130.1
327
469
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
9.0
128.7
283
328
L01BC59
ATC
trifluridine, combinations; systemic
+∞
128.6
123
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
126.5
121
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
125.7
1089
4784
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
124.4
119
*
JFB00
NOMESCO Finland
Partial resection of small intestine
10.8
123.3
245
236
176
Kela drug reimbursment
Regorafenib
+∞
122.3
117
*
N02BE01
ATC
paracetamol; systemic, rectal
2.3
121.1
4655
38752
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
12.9
119.2
217
174
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
1172.4
118.2
115
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
27.5
117.3
163
61
1XC07
NOMESCO Finland
NA
1141.1
115.0
112
*
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
+∞
114.9
110
*
A79
ICPC
Malignancy NOS
115.2
114.4
124
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
113.3
2565
17149
369
Kela drug reimbursment
Regorafenib
+∞
112.8
108
*
UJF30
NOMESCO Finland
Ileoscopy through colon
3.1
112.6
697
2466
8140/3-C18.5
ICD-O-3
Adenocarcinoma, NOS, of splenic flexure of colon
+∞
111.8
107
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
150.6
111.6
118
8
A02BC02
ATC
pantoprazole; systemic
1.9
110.5
3550
26825
JAH01
NOMESCO Finland
Laparoscopy
6.0
108.6
317
556
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
108.2
1797
10620
L02BB03
ATC
bicalutamide; oral
543.1
108.1
107
*
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
+∞
107.6
103
*
L02BG04
ATC
letrozole; oral
34.4
107.5
141
42
JFF10
NOMESCO Finland
Loop enterostomy
54.5
107.1
128
24
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
527.5
105.0
104
*
Y77
ICPC
Malignant neoplasm prostate
125.7
103.3
111
9
8480/3-C18.0
ICD-O-3
Mucinous adenocarcinoma of cecum
+∞
102.4
98
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.7
101.3
486
1414
C18.39
ICD-10 Finland
Malignant tumor of flexura hepatica other or unspecified histology
+∞
100.3
96
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.7
99.7
266
414
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.6
99.2
369
850
JFB54
NOMESCO Finland
Laparoscopic resection of sigmoid colon with partial proctectomy
207.6
98.7
102
5
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
26.6
98.7
138
53
JJB10
NOMESCO Finland
Atypcal resection of liver
491.1
97.7
97
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
325.8
96.2
97
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
96.0
1862
11549
WF004
NOMESCO Finland
Palliative radiotherapy
943.9
95.2
93
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
95.0
91
*
Z31.5
ICD-10 Finland
Genetic counselling
6.8
95.0
249
378
JFF23
NOMESCO Finland
Transversostomy
28.4
93.2
128
46
K56.7
ICD-10 Finland
Ileus, unspecified
7.3
92.8
232
329
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
49.6
92.2
112
23
HAC20
NOMESCO Finland
Total mastectomy
193.1
91.5
95
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
162.7
91.4
96
6
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
+∞
90.8
87
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
90.6
547
1889
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.2
90.2
369
931
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.8
90.1
316
684
JFB50
NOMESCO Finland
Other resection of colon
37.8
89.8
115
31
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.5
89.6
221
307
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
881.8
88.9
87
*
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
+∞
87.7
84
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.7
87.0
314
700
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
86.9
752
3239
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
86.8
771
3368
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
5.6
85.6
263
490
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
7.6
85.5
208
283
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
84.6
81
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
84.6
81
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.3
83.4
121
53
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.6
82.8
252
464
L01XE21
ATC
[U] regorafenib; oral
+∞
82.5
79
*
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
+∞
80.4
77
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
77.1
80.3
91
12
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
403.0
80.1
80
*
JFB40
NOMESCO Finland
Resection of transverse colon
66.0
78.6
91
14
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
66.0
78.6
91
14
8480/3-C18.2
ICD-O-3
Mucinous adenocarcinoma of ascending colon
+∞
78.3
75
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
392.7
78.0
78
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
17.3
77.9
125
74
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
77.2
74
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
387.5
77.0
77
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.1
76.9
321
823
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
76.2
73
*
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
+∞
76.2
73
*
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
5.0
75.0
255
533
E0000UV
ATC
NA
1.8
74.9
2003
13549
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
6.2
74.7
209
346
TJF80
NOMESCO Finland
Ostomy education
22.9
74.1
108
48
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.6
73.7
362
1067
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
8.6
73.7
165
197
WX600
NOMESCO Finland
Single shot through catheter
15.8
73.5
122
79
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.5
73.4
155
167
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
73.0
70
*
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
16.4
72.8
119
74
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
72.0
69
*
C18.6
ICD-10 Finland
Malignant neoplasm: Descending colon
+∞
72.0
69
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
361.7
71.8
72
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.1
71.7
205
349
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
8.6
71.7
160
190
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
51.3
71.4
86
17
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
71.0
68
*
C18.62
ICD-10 Finland
Malignant tumor of the descending colon carcinoma of the adenoma
+∞
71.0
68
*
B01AB04
ATC
dalteparin; parenteral
3.4
70.7
374
1167
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.3
70.6
381
1208
WX704
NOMESCO Finland
Intubation
3.0
70.0
447
1592
Z93.3
ICD-10 Finland
Colostomy status
23.3
69.8
101
44
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.5
69.5
257
586
C18.59
ICD-10 Finland
Malignant tumor in flexura lienalis other or unspecified histology
+∞
68.9
66
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
68.6
609
2636
HA1AA
NOMESCO Finland
X-ray mammography
4.8
68.1
240
521
NK6AN
NOMESCO Finland
Total body bone isotope imaging
26.5
67.4
94
36
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.4
66.9
351
1088
R4110
NOMESCO Finland
Physiotherapy
1.8
66.1
1367
8442
C50.99
ICD-10 Finland
Breast, unspecified
+∞
64.7
62
*
6404
FHL
Hemicolectomy on the right
52.0
64.2
77
15
UJF34
NOMESCO Finland
Left colonoscopy
13.2
63.9
114
88
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
63.6
61
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
10.6
63.1
125
120
V03AF03
ATC
calcium folinate; systemic
624.8
62.9
62
*
C18.69
ICD-10 Finland
Malignant tumor of colon descendens other or unspecified histology
+∞
62.6
60
*
L02BA01
ATC
tamoxifen; oral
71.7
62.2
71
10
D77
ICPC
Malignant digestive neopl other/NOS
133.5
62.0
66
5
C18.5
ICD-10 Finland
Malignant neoplasm: Splenic flexure
+∞
61.5
59
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
316.2
61.5
62
*
JKA20
NOMESCO Finland
Cholecystectomy
3.9
60.6
265
707
C18.12
ICD-10 Finland
Malignant tumor of the appendix carcinoma of the adenoma
+∞
60.5
58
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
310.8
60.4
61
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.4
60.1
147
202
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
129.4
59.9
64
5
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.6
59.8
102
71
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
59.5
57
*
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
16.1
59.2
97
61
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
58.4
56
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
58.4
56
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
57.8
962
5471
C18.32
ICD-10 Finland
Malignant tumor of flexura hepatica carcinoma of adenoma
+∞
57.4
55
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
57.4
55
*
8480/3-C18.7
ICD-O-3
Mucinous adenocarcinoma of sigmoid colon
+∞
57.4
55
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
151.5
56.9
60
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
104.4
56.9
62
6
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
289.5
56.3
57
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
284.1
55.3
56
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
18.7
54.9
85
46
SPAT1153
SPAT
Removal of sutures
1.7
54.6
1656
11356
ZX080
NOMESCO Finland
Image guided radiotherapy
278.8
54.2
55
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
278.8
54.2
55
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
54.2
52
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
54.2
52
*
D37.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Appendix
32.6
53.9
71
22
S18
ICPC
Laceration/cut
1.6
53.8
2103
15402
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
53.6
371
1388
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
37.6
52.6
67
18
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
52.1
50
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
52.1
50
*
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
43.1
51.6
64
15
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
51.1
49
*
R50.9
ICD-10 Finland
Fever, unspecified
2.0
51.0
687
3586
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
50.4
200
489
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.6
50.1
83
54
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
50.1
48
*
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
8.0
49.1
114
145
C18.81
ICD-10 Finland
Malignant overall tumor of the colon invasive carcinoma
+∞
49.0
47
*
WX110
NOMESCO Finland
Local anesthesy
1.5
48.9
3029
24518
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
24.9
48.9
69
28
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
48.0
46
*
8140/3-C18.1
ICD-O-3
Adenocarcinoma, NOS, of appendix
+∞
48.0
46
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
48.0
46
*
K92.1
ICD-10 Finland
Melaena
2.6
47.5
384
1570
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
68.0
47.1
54
8
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
68.0
47.1
54
8
R4190
NOMESCO Finland
Nutritional therapy
4.8
47.0
162
344
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
46.9
45
*
8480/3-C18.4
ICD-O-3
Mucinous adenocarcinoma of transverse colon
+∞
46.9
45
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
46.9
45
*
ZXC96
NOMESCO Finland
Robot assisted procedure
10.5
46.9
93
90
JFF13
NOMESCO Finland
Terminal enterostomy
28.1
46.9
64
23
JFB20
NOMESCO Finland
Ileocaecal resection
16.4
46.8
76
47
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
16.6
45.9
74
45
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
45.9
44
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
45.9
44
*
TPX15
NOMESCO Finland
Removal of vascular injection port
20.8
45.6
68
33
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
59.4
45.3
53
9
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
451.1
45.3
45
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
45.2
425
1883
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
44.8
43
*
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
+∞
44.8
43
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.1
44.8
265
894
JEA00
NOMESCO Finland
Appendectomy
2.8
44.7
307
1140
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
8.2
44.3
101
125
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.0
43.9
146
299
8480/3-C18.9
ICD-O-3
Mucinous adenocarcinoma of colon, NOS
+∞
43.8
42
*
A06AH03
ATC
naloxegol; oral
13.7
43.7
76
56
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
57.1
43.4
51
9
SPAT1125
SPAT
Stoma care and guidance
4.8
43.0
148
314
J01MA12
ATC
levofloxacin; systemic
1.7
42.9
963
5983
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
147.7
41.8
44
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.6
41.4
149
332
WX002
NOMESCO Finland
Sedation and analgesia
1.7
41.2
1032
6619
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.3
40.9
159
382
Z51.0
ICD-10 Finland
Radiotherapy session
211.4
40.9
42
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
40.7
39
*
C18.80
ICD-10 Finland
Malignant overall tumor of the colon without histology
+∞
40.7
39
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
16.8
40.6
65
39
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
53.7
40.5
48
9
JFC10
NOMESCO Finland
Ileotransversostomy
400.1
40.1
40
*
UJG02
NOMESCO Finland
Proctoscopy
4.4
40.0
151
353
JEA01
NOMESCO Finland
Laparoscopic appendectomy
3.8
39.9
176
474
R18
ICD-10 Finland
Ascites
5.3
39.5
124
238
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.4
39.4
146
335
128
Kela drug reimbursment
Cancers of female genital organs
389.9
39.1
39
*
C50
ICD-10 Finland
Malignant neoplasm of breast
201.2
38.8
40
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
38.6
37
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
38.6
37
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
17.1
38.4
61
36
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
17.8
38.3
60
34
K65.0
ICD-10 Finland
Acute peritonitis
5.5
38.0
116
216
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.8
37.9
131
280
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
196.2
37.8
39
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
20.9
37.8
56
27
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
134.2
37.7
40
*
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
134.2
37.7
40
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.8
37.7
109
190
C18.52
ICD-10 Finland
Malignant tumor of flexura lienalis carcinoma of adenoma
+∞
37.5
36
*
1534A
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]
+∞
37.5
36
*
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
61.8
37.1
43
7
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
369.6
37.0
37
*
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.2
36.5
144
351
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
36.5
35
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.7
36.4
258
978
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.1
36.0
116
230
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
98.1
35.7
39
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
127.4
35.7
38
*
3AC01
NOMESCO Finland
NA
6.0
35.6
101
172
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
35.4
34
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.5
35.4
296
1231
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
349.2
35.0
35
*
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
15.5
34.7
57
37
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
+∞
34.4
33
*
1533A
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]
+∞
34.4
33
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
34.4
33
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
34.4
33
*
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
2.4
34.0
300
1284
JFA42
NOMESCO Finland
Endoscopic injection in colon
12.6
33.9
61
49
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
3.5
33.9
163
473
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.3
33.8
129
305
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
175.9
33.7
35
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
9.0
33.7
72
81
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
33.3
32
*
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
33.3
32
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.0
33.3
197
664
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
15.0
33.0
55
37
KCD10
NOMESCO Finland
Partial cystectomy
90.6
32.7
36
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
21.0
32.6
48
23
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
32.4
493
2673
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
32.3
31
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
32.3
31
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
32.3
31
*
L02BX02
ATC
degarelix; parenteral
+∞
32.3
31
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
32.3
31
*
Z93.2
ICD-10 Finland
Ileostomy status
17.1
32.2
51
30
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
20.1
32.1
48
24
L02BG03
ATC
anastrozole; oral
72.5
31.8
36
5
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
88.0
31.7
35
*
JJB30
NOMESCO Finland
Excision of two segments of liver
113.9
31.7
34
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.4
31.4
59
52
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
31.4
396
1996
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
31.3
30
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
31.3
30
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
21.1
31.2
46
22
E34.0
ICD-10 Finland
Carcinoid syndrome
85.5
30.7
34
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
30.7
230
898
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
110.6
30.7
33
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
11.0
30.4
58
53
N02AX02
ATC
tramadol; systemic, rectal
1.4
30.4
2027
16056
8480/3-C18.3
ICD-O-3
Mucinous adenocarcinoma of hepatic flexure of colon
+∞
30.2
29
*
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
18.5
30.0
46
25
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
29.8
179
611
ZZR00
NOMESCO Finland
Flap of skin
6.7
29.4
76
115
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.8
29.3
75
112
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
29.3
240
988
UKC02
NOMESCO Finland
Cystoscopy
1.6
29.3
831
5462
ZX050
NOMESCO Finland
Stereotactic radiotherapy
26.8
29.2
40
15
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
29.2
28
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.7
28.9
201
752
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
293.2
28.8
29
*
JFG36
NOMESCO Finland
Closure of terminal colostomy with anastomosis to rectum
25.1
28.7
40
16
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
5.8
28.5
82
143
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
9.2
28.5
60
66
WX882
NOMESCO Finland
High dependency care
3.1
28.5
164
544
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
28.4
149
463
R11
ICD-10 Finland
Nausea and vomiting
2.0
28.2
391
2043
ZX121
NOMESCO Finland
Central venous catheter
18.8
28.2
43
23
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
28.2
372
1907
1XC08
NOMESCO Finland
NA
+∞
28.1
27
*
D48.42
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum originating in the appendix
+∞
28.1
27
*
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
28.1
27
*
ZX112
NOMESCO Finland
Subcutaneous
6.6
28.0
73
112
JN4DD
NOMESCO Finland
Scout CT scan of torso
64.3
27.9
32
5
JFH10
NOMESCO Finland
Total colectomy and ileostomy
19.2
27.8
42
22
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.9
27.7
118
310
B80
ICPC
Iron deficiency anaemia
3.6
27.7
127
356
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
100.5
27.6
30
*
X76
ICPC
Malignant neoplasm breast female
100.5
27.6
30
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.9
27.6
92
191
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
8.5
27.4
60
71
SPAT1109
SPAT
Analgesia with portable analgesic pump
10.1
27.1
54
54
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
27.1
26
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
27.1
26
*
8000/3-C18.9
ICD-O-3
Neoplasm, malignant of colon, NOS
+∞
27.1
26
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
27.1
26
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.1
26
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
27.1
26
*
JAQ10
NOMESCO Finland
Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity
+∞
27.1
26
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
27.1
26
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
26.9
525
3096
L57.0
ICD-10 Finland
Actinic keratosis
1.9
26.8
425
2338
K56.0
ICD-10 Finland
Paralytic ileus
4.7
26.6
91
194
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
26.1
202
804
JN6AD
NOMESCO Finland
CT of torso and neck
10.1
26.1
52
52
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
26.0
25
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
26.0
25
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
26.0
25
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
26.0
25
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
60.3
25.9
30
5
JG1BG
NOMESCO Finland
MRI of rectum
31.1
25.9
34
11
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
72.9
25.8
29
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
261.6
25.7
26
*
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
135.5
25.6
27
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.9
25.4
54
61
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
25.1
365
1946
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
25.0
24
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
25.0
24
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
25.0
24
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
25.0
24
*
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
4.7
25.0
86
185
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.2
24.9
96
231
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
24.8
727
4797
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.9
24.7
82
170
J01MA02
ATC
ciprofloxacin; systemic
1.4
24.4
1870
15012
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
17.4
24.3
38
22
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
24.0
23
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
24.0
23
*
1536A
ICD-9 Finland
Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]
+∞
24.0
23
*
8243/3-C18.1
ICD-O-3
Goblet cell carcinoid of appendix
+∞
24.0
23
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
24.0
23
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
24.0
23
*
KC1GB
NOMESCO Finland
Cystography with X-ray
15.1
23.7
39
26
P01AB01
ATC
metronidazole; oral, rectal
1.4
23.6
1649
13010
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
12.4
23.5
42
34
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
14.5
23.3
39
27
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
23.3
373
2056
D99
ICPC
Disease digestive system other
5.1
23.2
74
147
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
54.2
23.0
27
5
8480/1-C18.1
ICD-O-3
Low grade appendiceal mucinous neoplasm of appendix
+∞
22.9
22
*
C18.89
ICD-10 Finland
Malignant overall tumor of the colon other or unspecified histology
+∞
22.9
22
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
10.5
22.7
44
42
H01CB03
ATC
lanreotide; parenteral
40.2
22.6
28
7
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
230.7
22.6
23
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
22.2
942
6758
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
52.2
22.1
26
5
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
52.2
22.1
26
5
LAE10
NOMESCO Finland
Unilateral oophorectomy
11.8
21.9
40
34
L01BC04
ATC
carmofur; oral
+∞
21.9
21
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
21.9
21
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
21.9
21
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
80.4
21.7
24
*
ZX100
NOMESCO Finland
Oral
4.1
21.6
85
210
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
115.4
21.6
23
*
Z43.2
ICD-10 Finland
Attention to ileostomy
31.2
21.4
28
9
JFB63
NOMESCO Finland
Other resection of colon with proximal colostomy and closure of distal stump
43.5
21.4
26
6
D64.8
ICD-10 Finland
Other specified anaemias
3.3
21.3
110
340
SPAT1131
SPAT
Colonoscopy
2.4
21.3
188
807
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
21.1
234
1117
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.9
21.1
87
224
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
50.2
21.1
25
5
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.6
21.1
161
639
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
33.9
21.1
27
8
LCD00
NOMESCO Finland
Hysterectomy
2.4
21.0
184
787
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
20.9
768
5331
D50
ICD-10 Finland
Iron deficiency anaemia
3.4
20.9
101
297
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
11.2
20.9
39
35
C18.82
ICD-10 Finland
Malignant overall tumor of colon carcinoma of adenoma
+∞
20.8
20
*
C18.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of colon
+∞
20.8
20
*
8210/3-C18.7
ICD-O-3
Adenocarcinoma in adenomatous polyp of sigmoid colon
+∞
20.8
20
*
L02BB04
ATC
enzalutamide; oral
+∞
20.8
20
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
20.8
20
*
JJA20
NOMESCO Finland
Open biopsy of liver
14.8
20.6
34
23
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
12.9
20.6
36
28
WX892
NOMESCO Finland
Monitored bed care
1.8
20.6
374
2149
XKD00
NOMESCO Finland
Uroflowmetry
1.5
20.5
763
5313
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
3.5
20.5
98
286
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
20.5
265
1350
6434
FHL
Anterior resection
16.9
20.4
32
19
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
16.9
20.4
32
19
TQW20
NOMESCO Finland
Tatoe
41.8
20.4
25
6
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
22.4
20.3
29
13
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
4.9
20.3
67
139
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
14.2
20.3
34
24
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
48.1
20.1
24
5
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
19.9
185
815
WX290
NOMESCO Finland
Other blockade of nerve
1.4
19.9
1451
11460
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
5.3
19.9
61
117
8244/3-C18.1
ICD-O-3
Mixed adenoneuroendocrine carcinoma of appendix
+∞
19.8
19
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
200.5
19.6
20
*
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
4.2
19.5
74
177
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
24.6
19.5
27
11
JFH96
NOMESCO Finland
Other total colectomy
40.2
19.5
24
6
XQ902
NOMESCO Finland
Other photography
7.2
19.5
47
66
JAL00
NOMESCO Finland
Biopsy of peritoneum
19.4
19.5
29
15
Z43.3
ICD-10 Finland
Attention to colostomy
19.4
19.5
29
15
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
26.1
19.1
26
10
KAC10
NOMESCO Finland
Total nephrectomy with capsule
20.1
19.0
28
14
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
18.7
18
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
18.7
18
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
18.7
18
*
15302
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Cacci
+∞
18.7
18
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
18.7
18
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
18.7
18
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
18.7
18
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
18.7
420
2573
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
11.8
18.7
34
29
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
3.6
18.7
85
239
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
70.1
18.7
21
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
70.1
18.7
21
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
70.1
18.7
21
*
JFF30
NOMESCO Finland
Other colostomy
27.9
18.7
25
9
H01CB02
ATC
octreotide; parenteral
23.7
18.6
26
11
Z93
ICD-10 Finland
Artificial opening status
18.7
18.6
28
15
K83.1
ICD-10 Finland
Obstruction of bile duct
4.6
18.6
65
144
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
190.5
18.5
19
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
18.5
718
5039
SPAT1255
SPAT
Intravenous administration of medicine
1.8
18.4
319
1808
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
16.2
18.3
29
18
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
18.2
178
803
JFF26
NOMESCO Finland
Sigmoidostomy
25.1
18.2
25
10
JFC20
NOMESCO Finland
Other enterocolostomy
52.6
17.9
21
*
DAB10
NOMESCO Finland
Partial excision of auricle
52.6
17.9
21
*
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
52.6
17.9
21
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
52.6
17.9
21
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.4
17.8
88
265
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
5.8
17.7
50
87
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
17.7
17
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
17.7
17
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
17.7
17
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
17.7
17
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
17.7
17
*
L02BG06
ATC
exemestane; oral
+∞
17.7
17
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
17.7
17
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
17.7
17
*
C90.0
ICD-10 Finland
Multiple myeloma
66.8
17.7
20
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
9.8
17.6
35
36
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
95.3
17.5
19
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
17.5
496
3234
C82.1
ICD-10 Finland
Follicular lymphoma grade II
180.4
17.5
18
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
180.4
17.5
18
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
180.4
17.5
18
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
11.5
17.4
32
28
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.8
17.3
110
392
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
7.2
17.2
41
57
JF2BD
NOMESCO Finland
Extensive colon CT
4.1
17.1
67
166
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.7
17.1
75
206
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
31.5
17.0
22
7
L02AE04
ATC
triptorelin; parenteral
50.1
17.0
20
*
B82
ICPC
Anaemia other/unspecified
2.4
16.9
141
588
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
10.7
16.9
32
30
UJK02
NOMESCO Finland
ERCP
2.5
16.8
128
509
TJA10
NOMESCO Finland
Laparocentesis
21.9
16.8
24
11
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
63.5
16.7
19
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
63.5
16.7
19
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
16.7
16
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
16.7
16
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
16.7
16
*
8240/3-C18.0
ICD-O-3
Neuroendocrine tumor, NOS, of cecum
+∞
16.7
16
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
16.7
16
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
16.7
16
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
16.7
16
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
16.7
16
*
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
+∞
16.7
16
*
L01CB01
ATC
etoposide; systemic
+∞
16.7
16
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
16.7
16
*
L01EX05
ATC
regorafenib; oral
+∞
16.7
16
*
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
16.6
175
820
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
12.7
16.6
29
23
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.4
16.6
80
237
J01DB01
ATC
cefalexin; oral
1.3
16.5
3760
34429
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
16.5
557
3784
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
170.3
16.5
17
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.9
16.4
102
361
ZXC20
NOMESCO Finland
Use of chemical agents
3.3
16.4
82
250
WX004
NOMESCO Finland
Patient-controlled sedation
6.9
16.3
40
58
A06AD11
ATC
lactulose; oral
1.4
16.3
781
5710
SPAT1262
SPAT
Handing over of treatment supplies
1.4
16.2
887
6646
WW200
SPAT
NA
0.5
16.1
153
2838
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
47.6
16.0
19
*
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
13.5
15.9
27
20
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
15.8
104
382
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
60.1
15.7
18
*
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
15.6
15
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
15.6
15
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
15.6
15
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
15.6
15
*
8000/3-C18.7
ICD-O-3
Neoplasm, malignant of sigmoid colon
+∞
15.6
15
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
15.6
15
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
15.6
15
*
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
15.6
15
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
+∞
15.6
15
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
15.6
15
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
15.6
15
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
15.6
15
*
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
160.3
15.5
16
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
10.0
15.4
30
30
JFA70
NOMESCO Finland
Suture of small intestine
9.4
15.4
31
33
S77
ICPC
Malignant neoplasm of skin
14.7
15.3
25
17
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
28.6
15.2
20
7
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
28.6
15.2
20
7
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
5.1
15.1
47
93
QX9VV
NOMESCO Finland
NA
45.1
15.0
18
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
15.0
575
4012
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
10.8
14.9
28
26
TQW40
NOMESCO Finland
Remowal of suture of skin
1.8
14.8
260
1479
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
56.8
14.8
17
*
ZXC40
NOMESCO Finland
Use of ultrasound
6.0
14.8
40
67
SPAT1088
SPAT
Blood transfusion
6.6
14.7
37
56
8000/3-C18.2
ICD-O-3
Neoplasm, malignant of ascending colon
+∞
14.6
14
*
L01CA04
ATC
vinorelbine; systemic
+∞
14.6
14
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
14.6
14
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
14.6
14
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
14.6
14
*
3049
Kela drug reimbursment
NA
+∞
14.6
14
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
14.6
14
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
14.6
14
*
1CD02
NOMESCO Finland
NA
+∞
14.6
14
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
150.3
14.5
15
*
KA1FN
NOMESCO Finland
Isotope renography
6.7
14.4
36
54
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.4
14.4
31
37
JFG29
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to rectum
36.1
14.4
18
5
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
3.3
14.4
71
215
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.8
14.1
46
96
JA3CT
NOMESCO Finland
Cathetrisation of abdominal cavity with CT guidance
42.5
14.1
17
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
11.9
14.0
25
21
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
11.9
14.0
25
21
N05AX08
ATC
risperidone; systemic
0.6
13.9
165
2880
L02AE03
ATC
goserelin; implant
8.8
13.9
29
33
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
53.4
13.8
16
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
7.8
13.8
31
40
WGA11
NOMESCO Finland
Planning of pain management
23.8
13.8
19
8
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
9.1
13.7
28
31
JAD10
NOMESCO Finland
Repair of incisional hernia
4.0
13.6
54
137
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
75.3
13.6
15
*
G04BE03
ATC
sildenafil; oral
5.9
13.5
37
63
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
13.5
13
*
L02BX03
ATC
abiraterone; oral
+∞
13.5
13
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
13.5
13
*
1XA03
NOMESCO Finland
NA
+∞
13.5
13
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
13.5
13
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
13.5
13
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
13.5
13
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
13.5
13
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
13.5
13
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
14.7
13.5
22
15
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.3
13.5
67
205
D74
ICPC
Malignant neoplasm stomach
140.2
13.4
14
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
140.2
13.4
14
*
XX1AD
NOMESCO Finland
Other CT-examination
140.2
13.4
14
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
140.2
13.4
14
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
13.4
154
752
JFB96
NOMESCO Finland
Other partial excision of intestine
18.2
13.3
20
11
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.6
13.3
99
392
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
3.1
13.2
73
241
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
10.4
13.2
25
24
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.0
13.1
52
132
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
40.1
13.1
16
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
40.1
13.1
16
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.7
13.1
86
317
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
13.1
856
6591
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
3.4
13.0
62
184
KFC10
NOMESCO Finland
Bilateral orchiectomy
50.1
12.8
15
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
50.1
12.8
15
*
B02AA02
ATC
tranexamic acid; systemic
1.5
12.7
438
2988
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.0
12.7
71
237
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
4.3
12.7
46
108
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
12.6
806
10200
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
70.0
12.6
14
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
32.1
12.6
16
5
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
12.5
663
4924
K63.5
ICD-10 Finland
Polyp of colon
3.0
12.5
70
234
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
12.5
12
*
15311
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Transverse colon, including hepatic and splenic flexures
+∞
12.5
12
*
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
12.5
12
*
8480/3-C18.8
ICD-O-3
Mucinous adenocarcinoma of overlapping lesion of colon
+∞
12.5
12
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
12.5
12
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
12.5
12
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
12.5
12
*
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
+∞
12.5
12
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
12.5
12
*
8480/3-C18.6
ICD-O-3
Mucinous adenocarcinoma of descending colon
+∞
12.5
12
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.4
12.5
101
419
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
17.3
12.5
19
11
JFA68
NOMESCO Finland
Endoscopic insertion of prosthetic tube into colon
130.2
12.4
13
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
12.3
256
1537
JWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gastroenterological surgery
7.1
12.2
29
41
XJH00
NOMESCO Finland
Transanal ultrasonography
1.7
12.2
281
1736
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
12.2
169
888
KAD00
NOMESCO Finland
Partial nephrectomy
15.9
12.1
19
12
RD211
NOMESCO Finland
NA
1.9
12.1
176
941
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
4.3
12.0
43
100
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
11.8
1117
9056
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
11.8
280
1743
JF2AB
NOMESCO Finland
Colongraphy with X-ray
11.7
11.8
21
18
NK6LA
NOMESCO Finland
Bone and joint kinetic X-ray examination
14.6
11.8
19
13
XX_20
NOMESCO Finland
Bioimpedance measurement
16.4
11.6
18
11
KBV10
NOMESCO Finland
Removal of stent from ureter
4.4
11.6
41
94
JFB41
NOMESCO Finland
Laparoscopic resection of transverse colon
30.0
11.6
15
5
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
65.0
11.6
13
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
3.1
11.6
61
196
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
18.9
11.6
17
9
ZXC15
NOMESCO Finland
Use of photodynamic technique
3.7
11.5
49
134
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
11.5
11
*
1531A
ICD-9 Finland
Malignant neoplasm of colon, Transverse colon[NEOPL MALIG COLI TRANSV,INVASIIVINEN KARSINOOMA]
+∞
11.5
11
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
11.5
11
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
11.5
11
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
11.5
11
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
11.5
11
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
11.5
11
*
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
+∞
11.5
11
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
11.5
11
*
15301
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Appendicis
+∞
11.5
11
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
11.5
11
*
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies                        
+∞
11.5
11
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
11.5
11
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
11.5
11
*
GDC00
NOMESCO Finland
Lobectomy of lung
13.6
11.4
19
14
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
120.2
11.4
12
*
K62.7
ICD-10 Finland
Radiation proctitis
120.2
11.4
12
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
120.2
11.4
12
*
JFF24
NOMESCO Finland
Laparoscopic transversostomy
120.2
11.4
12
*
D01
ICPC
Abdominal pain/cramps general
1.5
11.3
363
2438
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.6
11.3
49
136
JFC00
NOMESCO Finland
Entero-enterostomy
15.0
11.3
18
12
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
20.0
11.1
16
8
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
5.6
11.0
31
56
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.0
11.0
21
21
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
13.9
10.9
18
13
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
43.4
10.9
13
*
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.1
10.9
59
194
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
15.5
10.8
17
11
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.5
10.8
86
353
C10AX09
ATC
ezetimibe; oral
0.7
10.8
271
3990
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.7
10.7
69
254
WE198
NOMESCO Finland
Palliative cystotatic therapy
60.1
10.6
12
*
ZXC50
NOMESCO Finland
Cryotherapy
2.2
10.6
100
450
6406
FHL
Other column resection
9.2
10.5
21
23
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
10.4
87
368
XX1XN
NOMESCO Finland
Other isotope examination
110.1
10.4
11
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
110.1
10.4
11
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
10.4
10
*
8480/3-C18.5
ICD-O-3
Mucinous adenocarcinoma of splenic flexure of colon
+∞
10.4
10
*
15331
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Sigmoid colon
+∞
10.4
10
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
10.4
10
*
189
Kela drug reimbursment
Imatinib
+∞
10.4
10
*
L01XE01
ATC
[U] imatinib; oral
+∞
10.4
10
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
10.4
10
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
10.4
10
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
10.4
10
*
1534X
ICD-9 Finland
Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,EI HISTOLOGISTA VAHVISTUSTA]
+∞
10.4
10
*
8249/3-C18.0
ICD-O-3
Neuroendocrine tumor, grade 2 of cecum
+∞
10.4
10
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
10.4
10
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
10.4
10
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
10.4
10
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
10.4
10
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
10.4
10
*
C16.00
ICD-10 Finland
Cardia
+∞
10.4
10
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
10.4
10
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
KEB00
NOMESCO Finland
Biopsy of prostate
3.8
10.4
43
115
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
32.5
10.3
13
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
10.3
953
11553
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
10.2
270
1731
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
18.8
10.2
15
8
R31
ICD-10 Finland
Unspecified haematuria
1.4
10.2
443
3171
OAB42
SPAT
NA
0.4
10.1
52
1175
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.9
10.1
140
740
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.1
10.1
52
166
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
3.6
10.0
43
119
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
11.3
10.0
18
16
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
11.3
10.0
18
16
6405
FHL
Hemicolectomy on the left
11.3
10.0
18
16
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
10.0
1011
12141
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
14.6
10.0
16
11
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
10.0
876
7017
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
40.1
10.0
12
*
6407
FHL
Colectomy and ileorectostomy
40.1
10.0
12
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
9.8
1380
11701
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
3.6
9.8
42
116
KBV00
NOMESCO Finland
Insertion of stent into ureter
4.4
9.8
34
78
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
10.6
9.8
18
17
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.0
9.7
53
176
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
7.4
9.7
22
30
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
13.4
9.6
16
12
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
13.4
9.6
16
12
ZXA00
NOMESCO Finland
Right side
1.2
9.6
1237
10381
JN5AP
NOMESCO Finland
Total body PET (1 picture)
55.0
9.6
11
*
A21
ICPC
Risk factor for malignancy
55.0
9.6
11
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.3
9.6
604
4608
KA3EB
NOMESCO Finland
Antegrade pyelography
6.0
9.5
25
42
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.6
9.5
41
115
C56
ICD-10 Finland
Malignant neoplasm of ovary
100.1
9.4
10
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
100.1
9.4
10
*
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
4.0
9.4
36
91
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
9.4
9
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
9.4
9
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
9.4
9
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
9.4
9
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
+∞
9.4
9
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
9.4
9
*
1BC02
NOMESCO Finland
NA
+∞
9.4
9
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
9.4
9
*
8090/3-C44.0
ICD-O-3
Basal cell carcinoma, NOS, of skin of lip, NOS
+∞
9.4
9
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
9.4
9
*
8490/3-C18.0
ICD-O-3
Signet ring cell carcinoma of cecum
+∞
9.4
9
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
9.4
9
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
9.4
9
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
9.4
9
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
9.4
9
*
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
+∞
9.4
9
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
9.4
9
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
9.4
9
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
9.4
9
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.4
9
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
9.4
9
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
9.4
9
*
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
+∞
9.4
9
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
9.4
9
*
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.6
9.3
67
262
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
12.3
9.3
16
13
JFG26
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to colon
21.7
9.3
13
6
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
10.6
9.3
17
16
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
2.7
9.3
60
223
JAH33
NOMESCO Finland
Opening of laparostomy
9.5
9.2
18
19
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.5
9.2
71
291
TJG20
NOMESCO Finland
Transanal irrigation
7.3
9.2
21
29
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.0
9.2
24
40
GDB10
NOMESCO Finland
Wedge resection of lung
13.7
9.2
15
11
N81.6
ICD-10 Finland
Rectocele
0.6
9.1
103
1816
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
7.7
9.1
20
26
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
9.1
149
836
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
9.1
690
5415
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.2
9.0
89
411
JFW98
NOMESCO Finland
Other transluminal endoscopic operation on intestine
36.7
9.0
11
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.6
8.9
136
2224
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
2.7
8.9
59
223
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
8.9
651
8129
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
3.9
8.9
35
91
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.8
8.9
134
732
WX872
NOMESCO Finland
Intensive care
1.6
8.9
235
1513
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.2
8.8
85
387
B03XA02
ATC
darbepoetin alfa; parenteral
2.3
8.8
77
336
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
4.3
8.8
31
73
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
6.3
8.8
22
35
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
8.7
608
4712
R10.0
ICD-10 Finland
Acute abdomen
1.9
8.7
124
663
A04AA03
ATC
tropisetron; systemic
50.0
8.7
10
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
50.0
8.7
10
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
5.8
8.6
23
40
A41.8
ICD-10 Finland
Other specified sepsis
2.4
8.6
72
308
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
11.6
8.6
15
13
D07AA02
ATC
hydrocortisone; topical
1.4
8.5
490
3684
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
90.1
8.4
9
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
90.1
8.4
9
*
L04AX04
ATC
lenalidomide; oral
90.1
8.4
9
*
C10AA07
ATC
rosuvastatin; oral
0.8
8.4
801
9704
N06DX01
ATC
memantine; oral
0.7
8.4
205
3038
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
8.4
288
1966
ZYC01
SPAT
NA
0.5
8.4
64
1259
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
7.8
8.3
18
23
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.2
8.3
41
128
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
6.7
8.3
20
30
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
8.3
8
*
15303
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Coli ascendentis
+∞
8.3
8
*
1532A
ICD-9 Finland
Malignant neoplasm of colon, Descending colon[NEOPL MALIG COLI DESCEND,INVASIIVINEN KARSINOOMA]
+∞
8.3
8
*
1541A
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]
+∞
8.3
8
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
8.3
8
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
8.3
8
*
1535C
ICD-9 Finland
Malignant neoplasm of colon, Appendix[NEOPL MALIG APPEND VERMIF,MUU TAI MÄÄRITTELEMÄTÖN H]
+∞
8.3
8
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
8.3
8
*
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
8.3
8
*
180
Kela drug reimbursment
Interferon alfa
+∞
8.3
8
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
8.3
8
*
U76
ICPC
Malignant neoplasm of bladder
+∞
8.3
8
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
8.3
8
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
8.3
8
*
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
+∞
8.3
8
*
1533X
ICD-9 Finland
Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,EI HISTOLOGISTA VAHVISTUSTA]
+∞
8.3
8
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
8.3
8
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
8.3
8
*
8144/3-C18.7
ICD-O-3
Adenocarcinoma, intestinal type of sigmoid colon
+∞
8.3
8
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
8.3
8
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
8.3
8
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
8.3
8
*
8000/3-C18.0
ICD-O-3
Neoplasm, malignant of cecum
+∞
8.3
8
*
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
+∞
8.3
8
*
Z71.8
ICD-10 Finland
Other specified counselling
1.3
8.2
831
6772
JDE00
NOMESCO Finland
Gastrojejunostomy
14.5
8.2
13
9
WX610
NOMESCO Finland
Patient controlled analgesia
5.1
8.1
24
47
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
5.1
8.1
24
47
D16
ICPC
Rectal bleeding
2.1
8.1
90
438
DHB00
NOMESCO Finland
Excision of lesion of external nose
5.7
8.1
22
39
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
33.4
8.1
10
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
17.2
8.1
12
7
TKE10
NOMESCO Finland
Puncture of prostate
17.2
8.1
12
7
HA1HA
NOMESCO Finland
Tomosynthesis mammography
11.7
8.1
14
12
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.6
8.0
56
218
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.6
8.0
56
218
N03AX16
ATC
pregabalin; oral
1.2
8.0
940
7788
K63.9
ICD-10 Finland
Disease of intestine, unspecified
3.9
8.0
31
80
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
22.0
8.0
11
5
M05BX04
ATC
denosumab; parenteral
1.7
8.0
171
1042
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
8.0
306
2137
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.5
8.0
286
1970
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.6
8.0
26
57
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
4.6
8.0
26
57
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.7
7.9
233
3329
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
13.0
7.9
13
10
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
7.9
127
710
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.2
7.9
28
67
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
7.7
7.9
17
22
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.7
7.8
185
2758
D06BX01
ATC
metronidazole; topical
1.4
7.8
366
2656
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
5.7
7.8
21
37
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
10.8
7.8
14
13
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
7.8
3945
37394
B81
ICPC
Anaemia vit B12/folate deficiency
1.6
7.8
180
1121
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
7.8
776
6310
K38.9
ICD-10 Finland
Disease of appendix, unspecified
45.0
7.7
9
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
45.0
7.7
9
*
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.6
7.7
51
194
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.7
7.6
235
3333
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
3.6
7.6
32
89
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
18.3
7.6
11
6
JFC30
NOMESCO Finland
Colo-colostomy
18.3
7.6
11
6
N02AA01
ATC
morphine; systemic, rectal
2.8
7.6
45
160
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.2
7.6
71
321
SPAT1290
SPAT
Preparation of deceased person
8.0
7.6
16
20
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
8.0
7.6
16
20
D78
ICPC
Neoplasm digestive benign/unspecif
8.0
7.6
16
20
A28
ICPC
Limited function/disability NOS
1.3
7.6
789
6449
C03CA01
ATC
furosemide; systemic
1.2
7.6
1681
14850
JLC10
NOMESCO Finland
Distal pancreatectomy
10.0
7.5
14
14
G03HA01
ATC
cyproterone; systemic
10.0
7.5
14
14
J01MA14
ATC
moxifloxacin; systemic
1.4
7.5
332
2388
G04CA02
ATC
tamsulosin; oral
1.2
7.5
1218
10446
M25.5
ICD-10 Finland
Pain in joint
0.8
7.4
730
8830
1XC03
NOMESCO Finland
NA
80.1
7.4
8
*
KAC20
NOMESCO Finland
Nephroureterectomy
80.1
7.4
8
*
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
80.1
7.4
8
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
80.1
7.4
8
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
80.1
7.4
8
*
WGA10
NOMESCO Finland
Measurement of pain intensity
80.1
7.4
8
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
80.1
7.4
8
*
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.2
7.4
68
307
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
13.3
7.4
12
9
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
3.2
7.4
36
113
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.5
7.4
24
53
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
4.5
7.4
24
53
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
7.3
1897
16965
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.8
7.3
43
152
KE1BG
NOMESCO Finland
MRI of prostate
8.3
7.3
15
18
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.3
7.3
15
18
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
4.7
7.3
23
49
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
+∞
7.3
7
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
7.3
7
*
1CB02
NOMESCO Finland
NA
+∞
7.3
7
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
7.3
7
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
7.3
7
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
7.3
7
*
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
+∞
7.3
7
*
8246/3-C18.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of appendix
+∞
7.3
7
*
1523
Kela drug reimbursment
NA
+∞
7.3
7
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
7.3
7
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
7.3
7
*
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
+∞
7.3
7
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
7.3
7
*
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
8010/3-C18.4
ICD-O-3
Carcinoma, NOS, of transverse colon
+∞
7.3
7
*
3054
Kela drug reimbursment
NA
+∞
7.3
7
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
7.3
7
*
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
+∞
7.3
7
*
8010/3-C18.9
ICD-O-3
Carcinoma, NOS, of colon, NOS
+∞
7.3
7
*
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
7.3
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.3
7
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
+∞
7.3
7
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
7.3
7
*
K91.3
ICD-10 Finland
Postoperative intestinal obstruction
10.8
7.3
13
12
R52.0
ICD-10 Finland
Acute pain
1.9
7.3
95
496
K62.1
ICD-10 Finland
Rectal polyp
2.5
7.3
54
217
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
3.8
7.2
28
73
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
0.7
7.2
187
2734
KCH00
NOMESCO Finland
Suture of bladder
5.8
7.2
19
33
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
7.2
883
10440
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
4.6
7.2
23
50
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
30.0
7.1
9
*
EAA30
NOMESCO Finland
Partial excision of lower lip
30.0
7.1
9
*
153
Kela drug reimbursment
Lenalidomid
30.0
7.1
9
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
20.0
7.1
10
5
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
20.0
7.1
10
5
K37
ICD-10 Finland
Unspecified appendicitis
4.4
7.1
24
55
N06DA02
ATC
donepezil; oral
0.7
7.1
172
2546
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
4.2
7.1
25
60
A02BC05
ATC
esomeprazole; systemic
1.2
7.1
1701
15114
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
4.5
7.0
23
51
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
4.5
7.0
23
51
E87.6
ICD-10 Finland
Hypokalaemia
1.7
7.0
127
738
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.5
7.0
51
1021
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.6
7.0
84
1454
SPAT1078
SPAT
Removal of central venous or arterial cannula
7.0
7.0
16
23
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
3.1
7.0
36
118
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.7
6.9
142
856
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.7
6.9
45
169
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.6
6.9
170
1078
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
13.8
6.9
11
8
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
4.6
6.9
22
48
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.1
6.9
72
346
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
6.9
25
62
XW000
NOMESCO Finland
Bone marrow biopsy
1.8
6.8
115
656
E86
ICD-10 Finland
Volume depletion
1.7
6.8
120
692
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.1
6.8
76
373
TKC20
NOMESCO Finland
Catheterisation of bladder
1.4
6.8
309
2234
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
2.6
6.8
45
172
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
6.7
6.8
16
24
SPAT1254
SPAT
Administration of medicine
1.3
6.8
652
5274
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
3.2
6.7
32
99
D18
ICPC
Change in faeces/bowel movements
2.0
6.7
84
431
M48.0
ICD-10 Finland
Spinal stenosis
0.8
6.7
375
4857
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.2
6.7
7
330
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
22.5
6.7
9
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
22.5
6.7
9
*
ZSJ00
NOMESCO Finland
Procedure related to previous procedure classified in chapter J
7.8
6.6
14
18
ZQZ00
NOMESCO Finland
Treatment of several skin areas
5.9
6.6
17
29
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
10.0
6.5
12
12
JFA73
NOMESCO Finland
Excision of lesion of small intestine
10.0
6.5
12
12
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
5.0
6.5
19
38
UKB02
NOMESCO Finland
Retrograde ureteroscopy
2.7
6.5
42
158
F03
ICD-10 Finland
Unspecified dementia
0.6
6.4
130
1997
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
69.9
6.4
7
*
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
69.9
6.4
7
*
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
69.9
6.4
7
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
7.4
6.4
14
19
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
14.3
6.4
10
7
T73
ICPC
Neoplasm endocrine other/unspecified
14.3
6.4
10
7
D06BB10
ATC
imiquimod; topical
1.7
6.4
130
787
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.3
6.4
56
250
N32.1
ICD-10 Finland
Vesicointestinal fistula
4.9
6.3
19
39
ZZA50
NOMESCO Finland
Full thickness skin graft
6.5
6.3
15
23
5702
FHL
Local lymph node removal (eg armpit, groin)
11.0
6.3
11
10
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
11.0
6.3
11
10
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
11.0
6.3
11
10
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
6.3
1036
11933
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.4
6.3
325
2406
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
18.0
6.3
9
5
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
18.0
6.3
9
5
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
6.2
6
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
6.2
6
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
6.2
6
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
6.2
6
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
6.2
6
*
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
+∞
6.2
6
*
1536X
ICD-9 Finland
Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,EI HISTOLOGISTA VAHVIS]
+∞
6.2
6
*
L01EC03
ATC
encorafenib; oral
+∞
6.2
6
*
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
6.2
6
*
1820A
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]
+∞
6.2
6
*
1733A
ICD-9 Finland
Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]
+∞
6.2
6
*
B72
ICPC
Hodgkin Lymphoma
+∞
6.2
6
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
6.2
6
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
6.2
6
*
198
Kela drug reimbursment
Sorafenib
+∞
6.2
6
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
6.2
6
*
316
Kela drug reimbursment
Imatinib
+∞
6.2
6
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
6.2
6
*
390
Kela drug reimbursment
Ibrutinib
+∞
6.2
6
*
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
+∞
6.2
6
*
U77
ICPC
Malignant neopl urinary tract other
+∞
6.2
6
*
1512
Kela drug reimbursment
Ibrutinib
+∞
6.2
6
*
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
+∞
6.2
6
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
6.2
6
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
+∞
6.2
6
*
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
6.2
6
*
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
+∞
6.2
6
*
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
+∞
6.2
6
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
6.2
6
*
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
6.2
6
*
15321
ICD-8 Finland
Malignant neoplasm of large intestine, except rectum, Descending colon
+∞
6.2
6
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
6.2
6
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
6.2
6
*
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
+∞
6.2
6
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
6.2
6
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
6.2
6
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
6.2
6
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
6.2
6
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
6.2
6
*
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
+∞
6.2
6
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
6.2
6
*
JGB36
NOMESCO Finland
Wide excision of rectum
+∞
6.2
6
*
A07DA03
ATC
loperamide; oral
1.6
6.2
142
886
XW2AT
NOMESCO Finland
Cytology of deep organ with ultrasound quidance
26.7
6.2
8
*
M01AC06
ATC
meloxicam; systemic, rectal
0.8
6.2
1206
13702
L01
ICPC
Neck symptom/complaint
0.7
6.2
285
3787
N06DA03
ATC
rivastigmine; oral, transdermal
0.6
6.2
102
1634
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
6.2
914
7754
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
6.3
6.1
15
24
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.7
6.1
40
151
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
2.6
6.1
41
159
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.0
6.1
68
334
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
1.9
6.1
83
441
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
6.1
79
414
LCD30
NOMESCO Finland
Radical hysterectomy
12.5
6.1
10
8
RS220
NOMESCO Finland
NA
2.5
6.0
43
170
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.1
6.0
30
97
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
4.9
6.0
18
37
GEA00
NOMESCO Finland
Mediastinoscopy
6.7
6.0
14
21
JF1BD
NOMESCO Finland
Very extensive small bowel CT
3.3
6.0
27
81
N05AH04
ATC
quetiapine; oral
0.8
6.0
346
4463

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
327
286
11.88
318.07
4.8
1.5
nmol/l
7.9
4.2
1.05
321
275
(3022145) Colonoscopy Study observation
2890
6012
6.97
307.65
1.4
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1794
1257
18.13
307.65
5.5
1.8
u/ml
1623.2
75.8
2.57
1611
1013
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2298
8893
3.23
307.65
2.2
2.7
%
17.8
22.0
36.06
2061
7377
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3242
13467
3.37
307.65
2.9
2.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
2486
10374
3.03
307.65
2.3
2.6
umol/l
10.7
12.5
23.06
2376
9441
(3002256) Pathology report gross observation
1403
4574
3.51
307.65
1.4
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2388
9519
3.15
307.65
2.2
2.6
g/l
2.4
2.3
24.88
2297
8680
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5553
30122
3.78
307.65
13.6
3.8
umol/l
11.7
12.2
2.18
5428
28101
(3013650) Neutrophils [#/volume] in Blood by Automated count
5151
32293
2.68
307.65
15.7
6.1
e9/l
4.0
4.4
23.99
4529
27475
(3023368) Bacteria identified in Blood by Culture
3354
17905
2.51
307.65
4.9
4.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4038
17607
3.62
307.65
3.2
2.2
—
—
—
0
0
(4035726)
1817
1704
13.52
307.65
1.4
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3924
18707
3.16
307.65
2.6
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3295
16996
2.60
307.65
2.4
2.3
mg/l
3.9
3.0
40.20
2895
14308
(3024561) Albumin [Mass/volume] in Serum or Plasma
5139
26712
3.60
307.65
9.1
3.8
g/l
33.6
35.2
67.54
4962
24253
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5083
26240
3.59
307.65
5.2
3.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
901
761
13.22
307.65
5.3
1.9
u/ml
219.9
426.8
0.44
816
684
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1897
4606
5.09
307.65
2.5
2.0
g/l
0.2
0.2
0.51
1826
4138
(3033658) Prothrombin time (PT) actual/Normal
3104
14412
2.89
307.65
5.3
3.6
%
87.0
84.9
4.51
3064
14029
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5615
3541
51.34
307.65
8.6
1.4
ug/l
32.7
7.1
5.32
5132
2675
(3032080) INR in Blood by Coagulation assay
4401
27296
2.37
301.08
9.8
11.0
inr
1.3
1.4
4.62
1141
7453
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6331
46673
2.74
288.18
15.0
5.4
u/l
92.7
76.8
48.90
6145
42963
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1578
6178
2.94
284.39
3.2
2.2
umol/l
9.6
8.2
1.25
1437
5289
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
362
454
8.30
269.88
2.1
1.8
u/ml
279.0
621.0
0.36
355
439
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3403
19587
2.29
268.36
3.0
2.3
u/l
55.1
59.8
5.00
3250
17884
(3037121) Protein [Mass/volume] in Urine
779
2085
4.03
256.15
5.6
2.5
g/l
0.2
0.3
12.63
582
716
(3014576) Chloride [Moles/volume] in Serum or Plasma
1791
8065
2.57
241.82
8.6
6.3
mmol/l
105.3
104.3
15.33
1758
7852
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3874
24308
2.16
237.81
3.1
2.9
ug/l
113.1
138.9
9.03
3602
22007
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1002
3330
3.30
237.14
8.6
9.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1291
5074
2.84
227.07
2.7
2.2
u/l
38.6
37.5
0.12
1153
4270
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1930
9252
2.43
225.97
4.8
2.4
mmol/l
0.8
0.8
16.69
1837
8384
(3015377) Calcium [Moles/volume] in Serum or Plasma
3343
20150
2.14
223.97
7.5
2.1
mmol/l
2.3
2.4
0.59
3039
16565
(3013826) Glucose [Moles/volume] in Serum or Plasma
5250
37542
2.17
223.11
6.2
4.5
mmol/l
6.9
6.9
0.07
5046
35051
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4701
32278
2.11
221.72
8.4
5.7
mmol/l
1.2
1.2
37.30
4044
26898
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
167
87
19.58
214.90
2.2
1.1
u/ml
18.5
16.9
0.45
161
76
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2257
11799
2.27
214.71
8.2
2.2
mmol/l
2.5
2.5
15.77
2115
10013
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1171
4515
2.87
212.59
1.6
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1425
6184
2.59
204.52
8.2
7.5
g/l
114.6
122.1
38.10
1391
5946
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4285
29157
2.02
198.11
7.4
5.3
mmol/l
1.2
1.2
24.09
3996
25647
(3016502) Oxygen saturation in Arterial blood
1518
6935
2.47
194.48
7.9
6.9
%
96.4
95.1
11.00
1480
6657
(3014111) Lactate [Moles/volume] in Serum or Plasma
1300
5635
2.56
185.63
6.8
6.4
mmol/l
1.3
1.4
6.14
1250
5414
(3003396) Base excess in Arterial blood by calculation
1599
7669
2.36
182.62
7.7
6.7
mmol/l
0.4
1.3
14.94
1312
5919
(3003694) ABO and Rh group [Type] in Blood
2437
13857
2.09
182.17
1.4
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1599
7686
2.35
181.59
7.7
6.7
kpa
13.9
11.5
51.85
1546
7278
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1599
7692
2.35
181.23
7.7
6.7
kpa
5.1
5.0
3.96
1548
7297
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
689
2164
3.39
176.79
2.4
3.0
u/ml
0.3
0.3
0.70
380
1279
(3000991) Gas panel - Venous blood
1208
5276
2.52
168.61
7.8
7.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
553
1605
3.63
159.95
3.3
1.5
u/ml
62.5
29.2
3.70
540
1510
(40758558) Short blood count panel - Blood
2318
13586
2.00
154.77
12.3
4.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2830
17859
1.91
151.01
4.7
2.6
u/l
40.3
35.7
0.59
2715
16702
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
852
3304
2.77
150.36
8.7
8.7
mmol/l
23.9
24.5
6.70
831
2992
(3020779) Urea [Moles/volume] in Serum or Plasma
1209
5825
2.27
132.92
5.7
6.7
mmol/l
9.6
11.4
12.95
1148
5463
(3019069) Monocytes/100 leukocytes in Blood
3829
27272
1.78
132.60
5.5
5.8
%
9.0
8.8
2.74
3572
25054
(42870588) Differential panel, method unspecified - Blood
3006
19943
1.81
132.43
5.0
5.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
3811
27132
1.78
131.95
5.3
5.5
%
2.7
3.0
11.67
3549
24817
(3002030) Lymphocytes/100 leukocytes in Blood
3880
27835
1.77
130.22
5.5
5.6
%
24.2
26.6
31.23
3596
25408
(3022096) Basophils/100 leukocytes in Blood
3714
26356
1.77
129.06
5.3
5.5
%
0.6
0.7
12.53
3460
24138
(40768441) Liver Pathology biopsy report
168
205
8.35
127.70
1.1
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1289
6489
2.18
126.71
3.2
2.6
u/l
245.6
243.7
0.16
1220
5993
(3002582) Erythrocytes [#/volume] in Urine
2890
19138
1.80
126.70
3.6
3.1
e6/l
58.4
110.8
2.13
2268
14599
(3042936) Bacteria identified in Isolate by Culture
1566
8529
2.04
124.82
2.1
2.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
100
56
18.07
124.26
2.9
1.1
u/ml
44.9
20.5
0.70
100
50
(3027945) Reticulocytes/100 erythrocytes in Blood
1466
7814
2.07
123.85
2.0
2.1
%
1.8
1.8
1.87
1300
6746
(3018010) Neutrophils/100 leukocytes in Blood
3801
27525
1.73
119.80
5.3
5.5
%
60.1
58.3
13.07
3549
25277
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
817
3515
2.48
115.39
7.1
7.2
mmol/l
24.4
24.8
2.58
811
3468
(3006315) Basophils [#/volume] in Blood
3969
29438
1.69
111.60
5.0
5.3
e9/l
0.0
0.0
7.56
3310
25030
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
432
1353
3.32
110.32
2.0
2.4
g/l
3.7
3.6
1.17
417
1278
(3001604) Monocytes [#/volume] in Blood
3934
29232
1.68
108.82
5.1
5.2
e9/l
0.6
0.6
2.91
3279
24819
(3030467) Casts [#/volume] in Urine by Automated count
2628
17535
1.74
108.18
3.5
3.0
e6/l
0.6
0.5
0.96
2024
13124
(3019198) Lymphocytes [#/volume] in Blood
4008
30019
1.67
106.79
5.2
5.3
e9/l
1.8
1.8
0.02
3411
25942
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
199
357
5.69
105.51
2.1
1.3
ug/l
18.6
20.7
0.34
194
344
(3013115) Eosinophils [#/volume] in Blood
4040
30404
1.67
104.97
5.3
5.4
e9/l
0.2
0.2
9.81
3426
26206
(3031040) Bacteria [#/volume] in Urine by Automated count
5150
41316
1.70
104.34
5.0
4.7
e6/l
1785.3
1868.1
0.03
75
685
(4281824)
176
289
6.20
102.23
1.1
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2510
16766
1.73
101.50
3.4
3.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1440
8135
1.94
101.11
4.8
5.3
mmol/l
1.0
1.0
3.92
1347
7419
(3018095) Leukocytes [#/volume] in Urine
3118
22175
1.67
99.06
4.1
3.6
e6/l
95.3
119.5
1.19
2348
15691
(3026782) Osmolality of Urine
1963
12349
1.78
97.32
3.1
2.7
mosm/kgh2o
547.7
548.4
0.05
1720
10312
(3023520) Reticulocytes [#/volume] in Blood
1096
5853
2.01
89.67
2.1
2.1
e9/l
70.1
68.5
0.70
825
4480
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
405
1394
3.01
87.93
2.0
2.1
%
81.8
89.3
7.60
393
1300
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
386
1298
3.07
87.29
2.0
2.4
%
213.2
194.3
3.67
372
1227
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1615
9916
1.79
85.44
3.2
2.8
e6/l
2.8
2.5
0.71
917
5406
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
486
1947
2.59
78.94
1.4
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
2639
18797
1.60
78.48
4.7
3.4
ph
7.4
7.4
2.28
533
3282
(3000850) Epithelial cells [#/volume] in Urine
1972
13364
1.63
70.49
2.8
2.5
e6/l
5.4
4.9
1.14
1741
11539
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4441
36199
1.51
68.31
3.8
3.0
u/l
70.5
49.8
19.09
4175
32808
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1565
10078
1.69
67.92
2.0
1.9
s
30.1
30.1
0.01
1529
9764
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
577
2669
2.25
67.87
2.0
1.8
ug/l
1.5
2.1
1.50
516
2290
(3026008) Bacteria identified in Urine by Culture
2738
20197
1.54
67.32
3.3
3.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1351
8407
1.73
66.35
1.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6740
60563
1.73
66.06
27.7
14.5
mg/l
37.1
24.9
119.47
6280
48116
(40768795) Lymph node Pathology biopsy report
92
126
7.37
63.39
1.1
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1654
11080
1.62
60.61
1.8
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
5069
43059
1.49
59.38
5.4
4.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1611
10893
1.60
56.26
3.1
2.6
e6/l
1.2
1.2
0.17
909
6326
(40768793) Breast Pathology biopsy report
135
299
4.57
56.24
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
432
1942
2.29
54.18
1.9
1.9
s
21.3
21.5
0.39
407
1710
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
233
776
3.06
53.47
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
66
75
8.86
53.08
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
614
3191
2.00
52.94
1.4
1.5
g/l
1.8
1.5
7.38
526
2711
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
694
3838
1.88
49.68
2.6
2.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1048
6580
1.68
48.52
3.5
3.6
kpa
5.6
5.9
12.28
1012
6377
(3021589) Normoblasts [#/volume] in Blood
3241
25902
1.42
48.38
14.6
8.9
e9/l
0.0
0.0
0.11
2570
21131
(3012544) pH of Venous blood
1076
6808
1.67
48.36
3.4
3.7
ph
7.4
7.4
—
6
31
(3039000) Anion gap in Blood
345
1477
2.40
48.36
7.6
6.7
mmol/l
11.2
11.4
0.43
319
1331
(3018572) Chloride [Moles/volume] in Blood
345
1477
2.40
48.36
7.7
6.7
mmol/l
106.2
104.7
7.04
319
1331
(40768800) Prostate Pathology biopsy report
158
441
3.63
48.15
1.2
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
560
2943
1.97
46.62
6.1
4.9
%
0.9
0.9
0.33
529
2773
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
564
2979
1.96
46.27
6.0
4.8
%
1.5
1.6
1.62
535
2807
(3002032) Base excess in Venous blood by calculation
1035
6570
1.66
45.76
3.5
3.6
mmol/l
1.6
2.0
1.54
805
5331
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
63
82
7.73
45.39
1.8
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
797
4776
1.74
43.51
5.9
4.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
754
4527
1.73
40.77
8.2
6.7
mmol/l
24.2
24.6
2.15
718
4207
(3025941) Bacteria identified in Stool by Culture
550
3015
1.88
40.23
1.3
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
44
5
88.53
39.79
1.1
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
418
2099
2.05
39.46
7.0
5.9
mmol/l
1.4
1.3
1.00
380
1870
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
29
13
22.38
39.34
1.1
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
549
3076
1.84
37.43
3.2
4.0
mmol/l
23.7
24.2
2.39
507
2715
(3004809) Band form neutrophils/100 leukocytes in Blood
202
771
2.66
36.08
2.5
2.8
%
2.3
1.2
2.71
160
569
(3019225) pH of Specimen
1005
6688
1.57
36.03
4.9
3.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
205
793
2.63
35.65
6.0
6.4
mg/l
11.9
12.4
0.77
183
708
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
299
1376
2.22
35.37
1.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
684
4163
1.70
35.01
1.7
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
348
1725
2.06
34.01
1.6
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
70
141
5.00
32.78
1.5
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
842
5492
1.60
32.71
3.2
3.1
kpa
4.6
4.4
0.87
808
5302
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
645
3941
1.69
32.47
1.6
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
6864
64352
1.48
30.86
33.2
17.7
mmol/l
139.3
139.7
41.69
6763
62519
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6177
56880
1.38
30.33
28.4
13.4
ml/min/173m2
75.6
73.9
8.61
5449
45840
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
483
2772
1.79
30.33
1.9
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
6869
64492
1.47
29.81
33.3
17.9
mmol/l
4.0
4.0
19.38
6758
62559
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1097
7735
1.48
29.64
1.8
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
110
335
3.31
29.44
1.3
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
943
6514
1.51
28.08
4.5
3.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
728
4752
1.59
28.02
3.2
3.6
%
1.0
0.8
1.01
279
1068
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
187
778
2.44
27.99
1.4
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
444
2546
1.79
27.94
1.8
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
181
750
2.45
27.34
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
180
744
2.45
27.34
1.4
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
38
50
7.63
27.14
6.1
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
180
747
2.44
27.10
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
179
743
2.44
26.94
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
180
758
2.41
26.26
1.4
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
267
1323
2.05
26.15
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
5723
52483
1.32
26.00
30.5
16.0
%
36.9
39.1
43.81
3696
33081
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1075
7737
1.45
25.88
1.8
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
695
4569
1.57
25.87
3.2
3.6
%
0.2
0.1
1.18
264
994
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
776
5240
1.53
25.60
4.3
3.1
mmol/l
1.2
1.2
0.83
713
4386
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3442
29606
1.29
25.45
2.2
2.1
pmol/l
89.7
94.0
6.30
2038
15138
(3013512) EKG study
2450
20156
1.31
25.44
4.6
4.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
2115
17051
1.33
25.38
1.6
1.6
nmol/l
20.5
20.3
0.14
1848
14328
(3017143) Hepatitis C virus Ab [Presence] in Serum
649
4261
1.57
24.25
1.4
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
161
674
2.42
23.83
1.2
1.1
g/l
1.6
1.5
0.76
153
594
(40761511) CBC panel - Blood by Automated count
6624
62324
1.37
23.56
27.2
14.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5293
48305
1.28
23.27
36.3
17.2
%
14.8
13.8
228.67
5232
47014
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
685
4598
1.54
23.16
1.4
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
4899
44397
1.27
22.20
4.5
4.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
66
175
3.79
21.86
3.1
2.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
337
1916
1.79
21.83
4.6
3.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
647
4344
1.53
21.81
3.0
3.5
%
0.8
0.5
1.79
181
796
(3049717) Cytology report of Urine Cyto stain
379
2234
1.73
21.67
2.9
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1874
15148
1.31
21.41
1.8
1.8
nmol/l
1183.7
1160.4
0.43
1420
11295
(3007853) Bacteria identified in Skin by Aerobe culture
983
7205
1.42
21.13
1.8
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6792
64423
1.37
20.79
18.5
9.5
u/l
25.2
25.2
0.01
6650
61296
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1716
13752
1.32
20.78
3.8
4.2
ng/l
401.4
547.4
0.44
1462
11644
(3013727) Leukocytes other/100 leukocytes in Blood
55
133
4.16
20.67
2.3
3.1
%
56.1
58.5
0.32
55
124
(3022217) INR in Platelet poor plasma by Coagulation assay
1353
10485
1.35
20.64
26.1
30.3
inr
1.4
1.5
1.39
207
1401
(3023487) Leukocytes [#/volume] in Peritoneal fluid
63
171
3.70
20.20
1.5
2.5
e6/l
9712.2
603.1
0.52
47
122
(3018405) Lactate [Moles/volume] in Arterial blood
410
2528
1.66
19.82
4.7
3.9
mmol/l
1.3
1.4
0.61
403
2473
(3023183) Ammonium ion [Moles/volume] in Plasma
237
1252
1.92
19.41
2.0
2.4
umol/l
32.8
33.3
0.07
201
1058
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1630
13128
1.30
18.76
1.8
1.7
mg/l
1.8
1.3
6.33
1333
10107
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
56
148
3.80
18.68
1.5
2.3
e6/l
14283.3
24519.1
0.28
39
79
(40760892) CBC W Ordered Manual Differential panel - Blood
1490
11879
1.31
18.45
4.2
4.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
641
4446
1.48
18.42
3.2
3.3
g/l
120.1
129.5
18.34
626
4331
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
167
794
2.13
18.36
3.8
4.9
iu/ml
710.2
845.8
0.11
24
115
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2657
22798
1.25
18.06
3.0
3.2
ng/l
1653.9
1716.7
0.26
2307
19694
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
399
2506
1.62
17.93
2.0
2.3
ug/l
335.0
695.6
2.91
387
2362
(3025159) Blasts/100 leukocytes in Blood
625
4337
1.48
17.91
3.2
3.7
%
0.0
0.3
0.94
206
868
(3030981) Hyaline casts [#/volume] in Urine by Automated count
523
3499
1.53
17.88
3.1
2.6
e6/l
0.3
0.3
0.17
517
3421
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3113
27225
1.24
17.64
4.1
4.1
ng/l
41.5
90.2
2.91
2503
20296
(3013707) Erythrocyte sedimentation rate by Westergren method
5013
46167
1.23
16.93
3.9
4.2
mm/h
17.8
13.1
53.16
4536
42206
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
234
1292
1.84
16.76
1.3
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
288
1692
1.73
16.71
1.2
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
16
0
+∞
16.67
1.1
0.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
86
317
2.73
16.66
2.4
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
285
1675
1.73
16.52
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
288
1700
1.72
16.43
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
85
319
2.68
15.93
5.9
4.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
103
432
2.40
15.34
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
222
1241
1.81
15.31
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
3468
30976
1.21
15.17
4.3
4.0
estimate
0.0
0.0
0.11
716
5082
(3044007) Cell count panel - Peritoneal fluid
48
134
3.60
14.86
1.7
2.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
496
3424
1.48
14.57
2.8
2.6
%
1.2
1.2
0.43
491
3403
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
174
917
1.92
14.46
1.4
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
3419
30589
1.21
14.44
5.8
5.2
estimate
0.0
0.0
0.64
719
5255
(3012501) Base excess in Blood by calculation
249
1468
1.72
14.32
4.1
4.1
mmol/l
2.8
2.6
0.34
177
984
(3013290) Carbon dioxide [Partial pressure] in Blood
249
1470
1.72
14.25
4.1
4.2
kpa
5.0
5.0
0.06
243
1425
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
485
3352
1.48
14.16
2.6
2.6
%
0.7
0.7
0.14
475
3202
(3027315) Oxygen [Partial pressure] in Blood
250
1481
1.71
14.13
4.1
4.2
kpa
8.9
8.4
2.65
244
1435
(3003434) Protein [Mass/volume] in Pleural fluid
157
807
1.96
14.05
1.4
1.5
g/l
31.4
28.9
1.69
138
698
(3000570) Elastase.pancreatic [Mass/mass] in Stool
284
1748
1.65
13.89
1.4
1.4
ug/g
243.5
284.2
2.65
186
1044
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
98
421
2.34
13.88
1.4
1.3
—
—
—
0
0
(3010421) pH of Blood
278
1711
1.65
13.61
3.9
4.1
ph
7.4
7.4
0.10
243
1425
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
66
237
2.80
13.51
1.4
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
66
237
2.80
13.51
1.4
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
66
237
2.80
13.51
1.4
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
16
17
9.43
13.43
5.9
3.8
umol/l
0.3
0.4
—
16
10
(3012441) Differential panel - Pleural fluid
126
609
2.09
13.39
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
76
296
2.58
13.30
1.4
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
76
296
2.58
13.30
1.4
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
54
175
3.10
13.26
1.5
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
673
4997
1.38
13.18
3.9
2.5
ml/min/173m2
62.5
60.8
0.62
317
2013
(3024731) MCV [Entitic volume]
6919
66601
1.29
13.10
42.7
21.1
fl
91.0
91.6
21.06
6843
65234
(3007461) Platelets [#/volume] in Blood
6917
66581
1.29
13.09
42.9
21.2
e9/l
251.3
241.7
21.93
6769
64337
(3026361) Erythrocytes [#/volume] in Blood
6919
66607
1.29
13.05
42.9
21.2
e12/l
4.3
4.5
165.18
6740
64064
(3035941) MCH [Entitic mass]
6918
66598
1.29
13.03
42.7
21.1
pg
29.9
30.5
77.26
6841
65231
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
53
172
3.09
12.99
1.5
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
53
172
3.09
12.99
1.5
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
6919
66615
1.29
12.98
43.2
21.3
g/l
126.2
135.1
307.65
6843
65257
(3010813) Leukocytes [#/volume] in Blood
6919
66618
1.29
12.95
42.9
21.2
e9/l
7.0
6.8
9.02
6751
64082
(3035350) Ketones [Presence] in Urine by Test strip
3403
30637
1.19
12.90
4.2
3.9
estimate
0.0
0.0
0.50
704
5197
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
65
238
2.74
12.85
1.4
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
237
1422
1.69
12.81
2.0
3.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
237
1422
1.69
12.81
1.2
1.2
titre
72.9
173.1
1.45
17
121
(3023199) Leukocytes [#/volume] in Pleural fluid
142
729
1.96
12.80
1.4
1.5
e6/l
1166.4
2723.4
2.02
109
531
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
94
413
2.29
12.68
1.4
1.3
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
24
44
5.47
12.56
1.4
2.5
%
63.5
66.0
0.10
14
32
(3028308) Erythrocytes [#/volume] in Pleural fluid
130
653
2.01
12.48
1.4
1.5
e6/l
148246.3
65092.2
0.68
81
381
(3007164) IgA [Mass/volume] in Serum or Plasma
1206
9795
1.27
12.47
1.4
1.3
g/l
2.6
2.7
0.30
658
5434
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
774
9966
0.75
12.35
1.3
1.3
iu/ml
41.7
38.5
0.24
253
3071
(3048689) Calprotectin [Mass/mass] in Stool
796
6127
1.33
12.32
1.9
2.1
ug/g
266.2
155.8
7.86
628
4729
(3051611) Lipemic interference index of Serum or Plasma
130
658
1.99
12.22
5.0
3.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
116
564
2.07
12.18
1.4
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
729
9419
0.75
11.89
1.2
1.2
u/ml
19.7
15.3
0.55
264
3386
(3020891) Body temperature
414
2878
1.46
11.76
5.6
4.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
121
608
2.00
11.63
1.9
2.4
u/ml
587.6
673.3
—
5
42
(3021879) Hepatitis B virus core Ab [Presence] in Serum
379
2608
1.48
11.35
1.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
238
1477
1.63
11.34
3.3
3.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
650
4922
1.35
11.22
4.3
4.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
107
522
2.06
11.17
1.3
1.4
mmol/l
6.5
6.7
0.18
100
473
(3008757) Leukocyte morphology finding [Identifier] in Blood
112
556
2.03
11.15
2.5
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
175
1005
1.76
11.13
3.3
3.4
%
59.0
58.9
0.03
175
1005
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
314
2096
1.52
10.92
2.4
2.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
334
2266
1.49
10.75
1.2
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
47
160
2.95
10.68
2.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1801
15505
1.21
10.67
4.4
3.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
111
560
2.00
10.59
1.5
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1431
16847
0.82
10.58
1.6
1.6
mmol/l
1.4
1.3
2.98
1209
13852
(3027273) Bicarbonate [Moles/volume] in Venous blood
505
3712
1.38
10.52
3.8
3.3
mmol/l
24.6
25.2
3.46
492
3595
(3035637) Corticotropin [Mass/volume] in Plasma
98
475
2.08
10.44
1.5
1.3
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
12
12
10.01
10.43
1.9
1.5
ng/l
213.8
209.2
0.05
12
12
(3017354) Segmented neutrophils/100 leukocytes in Blood
105
523
2.02
10.39
2.5
2.7
%
61.9
61.2
0.11
63
335
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
196
1186
1.67
10.35
1.4
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5714
59792
0.84
10.22
4.3
4.8
mmol/l
1.4
1.4
3.26
5103
54190
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5772
60336
0.84
10.14
4.3
4.8
mmol/l
4.5
4.5
2.10
5212
55101
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
233
1481
1.59
10.11
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
233
1482
1.59
10.08
1.2
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
860
6870
1.28
10.06
1.4
1.4
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
42
139
3.03
10.04
1.1
1.8
g/l
15.9
13.8
0.98
37
103
(21494815) CD4 cells/100 lymphocytes in Specimen
62
255
2.44
9.79
1.8
2.1
%
31.5
45.9
—
6
33
(3043409) Potassium [Moles/volume] in Arterial blood
319
2189
1.48
9.74
5.3
4.2
mmol/l
3.8
3.9
3.16
300
2054
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
33
96
3.45
9.71
2.2
2.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
28
73
3.84
9.65
4.1
1.3
u/l
62.4
48.5
—
8
28
(3009343) pH of Capillary blood
570
4330
1.34
9.64
4.1
3.5
ph
7.4
7.4
0.54
73
529
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1381
11689
1.22
9.63
1.2
1.2
u/ml
2.7
2.0
0.59
345
2995
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
104
532
1.97
9.59
1.3
1.3
u/l
297.3
308.5
0.10
99
493
(3042111) Morphology [Interpretation] in Bone marrow Narrative
144
821
1.77
9.46
1.4
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
575
4392
1.33
9.37
4.1
3.5
kpa
5.1
5.2
2.56
535
4014
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
96
482
2.00
9.34
1.4
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
67
292
2.30
9.33
2.2
1.9
e9/l
1.2
1.0
0.32
44
169
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
462
3433
1.37
9.03
4.6
4.0
%
47.4
47.2
0.05
456
3390
(3008037) Lactate [Moles/volume] in Venous blood
262
1756
1.51
9.00
3.8
3.3
mmol/l
1.6
1.7
0.01
256
1711
(3028626) Oxygen [Partial pressure] in Capillary blood
233
1523
1.55
8.99
3.5
2.8
kpa
8.1
7.8
0.92
217
1409
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
548
4186
1.33
8.93
4.1
3.4
mmol/l
1.8
1.9
0.48
399
3061
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
89
443
2.02
8.89
1.4
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
89
443
2.02
8.89
1.4
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
89
443
2.02
8.89
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
292
2009
1.47
8.83
5.3
4.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
100
521
1.93
8.78
1.4
1.4
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
40
141
2.85
8.61
1.2
1.3
ug/l
986.6
57.6
0.79
21
58
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
55
231
2.39
8.36
2.8
2.5
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
44
166
2.66
8.35
1.3
1.4
mmol/l
3.3
3.1
0.17
39
148
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
19
41
4.64
8.33
1.3
2.2
%
20.0
10.5
—
8
24
(21494814) CD8 cells/100 lymphocytes in Specimen
35
117
3.00
8.28
2.1
2.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
215
1408
1.54
8.26
2.2
2.5
%
15.6
16.3
1.45
110
750
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
58
254
2.29
8.04
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
58
254
2.29
8.04
1.2
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
21
51
4.12
7.98
1.1
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
104
570
1.84
7.86
3.1
2.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
49
203
2.42
7.70
2.3
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
200
1311
1.54
7.68
2.6
2.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
161
1010
1.61
7.49
2.7
2.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
44
176
2.51
7.46
5.5
1.1
u/ml
42.5
139.5
1.07
11
47
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
108
612
1.77
7.35
1.3
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
106
601
1.77
7.21
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5984
61919
0.86
7.04
4.9
5.5
mmol/l
2.6
2.6
3.17
5361
56330
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2799
25651
1.14
6.96
2.2
2.2
nmol/l
76.2
79.0
5.93
2502
22234
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
828
6867
1.23
6.95
3.1
3.2
ng/l
220.7
244.6
0.94
754
6297
(4034850)
147
2288
0.64
6.90
13.9
10.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
692
5645
1.25
6.77
2.5
1.6
g/l
64.9
66.5
5.61
613
4970
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
49
216
2.28
6.75
2.2
1.9
%
13.3
16.7
0.49
15
93
(3001893) Eosinophils/100 leukocytes in Pleural fluid
42
173
2.43
6.73
1.4
1.4
%
3.6
2.8
0.16
35
144
(3000330) Specific gravity of Urine by Test strip
476
3715
1.30
6.70
5.1
3.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5573
57847
0.88
6.42
3.9
4.3
mmol/l
1.3
1.3
4.68
4936
51922
(3011648) Oxygen content in Venous blood
88
492
1.80
6.33
1.7
2.1
%
10.8
11.0
0.14
88
492
(3017732) Neutrophils [#/volume] in Blood
506
4014
1.28
6.29
3.8
3.0
e9/l
4.1
4.1
0.04
369
2852
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
46
204
2.26
6.28
1.3
1.4
%
55.8
63.6
0.74
38
164
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
74
397
1.87
6.08
1.3
1.3
u/l
13.7
11.4
0.36
66
354
(3022313) Gas panel - Capillary blood
403
3118
1.31
6.08
4.6
3.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
101
597
1.70
6.01
1.1
1.2
u/l
83.7
57.2
1.09
62
381
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
48
221
2.18
6.00
2.0
1.9
e6/l
474.1
699.4
1.67
20
97
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
23
5.22
6.00
1.6
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
64
329
1.95
5.98
1.3
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
68
357
1.91
5.97
1.2
1.6
—
—
—
0
0
(3015736) pH of Urine
2627
24166
1.13
5.91
3.9
3.7
ph
5.9
5.4
—
5
7
(3015235) Bicarbonate [Moles/volume] in Capillary blood
251
1819
1.39
5.84
2.7
3.0
mmol/l
24.2
24.9
1.60
221
1600
(46235355) HIV 1 and 2 tests - Meaningful Use set
663
5483
1.23
5.73
1.5
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
590
4827
1.24
5.65
2.6
1.8
nmol/l
413.2
371.3
4.02
553
4312
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
5663
58573
0.88
5.61
6.5
6.6
mmol/mol
41.3
40.9
1.88
5104
53445
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
123
784
1.58
5.47
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
227
1641
1.39
5.39
1.6
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1731
15584
1.14
5.39
1.7
1.7
pmol/l
19298664.4
28575272.3
0.35
1425
12539
(1761868) Lipid panel - Serum or Plasma
1641
18203
0.88
5.32
3.0
3.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
178
1238
1.45
5.26
1.5
1.3
mmol/l
54.5
62.9
2.16
125
995
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
137
905
1.52
5.22
1.2
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
39
177
2.21
5.10
1.8
2.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
33
140
2.36
5.04
1.2
1.4
%
22.6
27.5
0.43
28
113
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
488
5958
0.81
4.95
1.6
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
218
1595
1.38
4.86
1.9
2.2
g/l
121.3
129.7
4.99
166
1172
(3005322) IgE [Units/volume] in Serum or Plasma
240
3179
0.75
4.71
1.2
1.3
u/ml
211.9
224.0
0.11
218
2928
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
72
417
1.73
4.70
1.5
1.8
u/l
247.5
1701.8
1.53
17
163
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
120
794
1.52
4.59
1.3
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
460
3752
1.24
4.58
2.6
2.2
g/l
10.4
10.8
0.93
418
3401
(3022493) Free Hemoglobin [Mass/volume] in Plasma
51
268
1.91
4.56
1.6
4.8
mg/l
68.3
82.5
0.52
35
181
(3002331) Protein [Mass/volume] in Peritoneal fluid
28
116
2.42
4.53
1.4
1.5
g/l
30.5
76.1
0.44
19
90
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
94
593
1.59
4.45
1.8
2.3
u/field
2.6
2.0
0.44
38
210
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
80
485
1.66
4.44
1.3
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
189
1374
1.38
4.42
1.7
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
18
60
3.00
4.39
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
35
3.72
4.36
1.5
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
24
555
0.43
4.35
1.0
1.0
ng/l
41.4
45.5
0.17
14
354
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
147
2073
0.70
4.32
1.4
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
63
361
1.75
4.30
1.4
1.5
u/l
2.4
7.5
2.33
25
153
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
24
552
0.43
4.30
1.0
1.0
ng/l
587.5
704.9
1.13
15
347
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
47
246
1.92
4.28
1.6
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
549
0.44
4.24
1.0
1.0
ng/l
269.9
334.8
1.00
14
358
(3044242) Glucose [Moles/volume] in Arterial blood
61
349
1.75
4.19
2.0
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
608
5158
1.19
4.10
3.6
3.8
ng/l
99.2
96.9
0.24
542
4307
(3019977) pH of Arterial blood
69
414
1.67
4.02
3.2
2.3
ph
7.4
7.4
0.72
25
149
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
172
1254
1.38
3.99
1.5
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
334
2672
1.26
3.99
5.0
3.8
mmol/l
24.7
24.9
0.62
299
2421
(3048929) Epstein Barr virus Ab [Presence] in Serum
142
1003
1.42
3.96
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
30
137
2.19
3.94
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3180
30058
1.10
3.85
2.4
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
185
1375
1.35
3.82
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
162
2194
0.73
3.77
1.1
1.2
u/ml
0.3
0.8
2.45
12
216
(44790049)
89
582
1.53
3.68
1.3
1.4
—
—
—
0
0
(44790047)
89
582
1.53
3.68
1.3
1.4
—
—
—
0
0
(44806118)
89
582
1.53
3.68
1.3
1.4
—
—
—
0
0
(44790048)
89
582
1.53
3.68
1.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
102
1486
0.68
3.65
1.6
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
254
3218
0.78
3.64
1.8
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
502
4238
1.20
3.60
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
573
4900
1.18
3.56
2.3
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
141
1017
1.39
3.53
1.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
67
414
1.62
3.53
2.5
2.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
31
151
2.06
3.50
1.4
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
364
2988
1.23
3.49
2.0
1.4
g/l
1.7
1.2
1.37
329
2687
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
63
2.70
3.48
1.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
262
2073
1.27
3.48
1.6
1.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
31
3.55
3.47
6.5
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
144
1047
1.38
3.45
1.7
1.5
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
52
306
1.70
3.32
1.1
1.1
u/l
33.7
24.8
0.45
42
220
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
112
787
1.43
3.28
1.3
1.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
52
307
1.70
3.28
1.1
1.1
u/l
87.7
89.2
0.05
45
231
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
336
2755
1.23
3.28
2.3
1.4
g/l
7.7
7.5
1.00
239
1976
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
335
2748
1.23
3.26
2.3
1.4
g/l
3.7
3.8
0.75
225
1911
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
335
2752
1.23
3.22
2.3
1.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
10
28
3.57
3.19
1.2
1.3
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
8
15
5.34
3.19
1.9
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
48
282
1.71
3.10
1.1
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4454
46085
0.92
3.10
3.7
3.9
pmol/l
15.0
15.0
0.15
3939
41061
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
48
283
1.70
3.07
1.1
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
113
807
1.41
3.05
1.3
1.2
nmol/l
0.6
3.9
1.00
105
771
(3006922) Hepatitis E virus Ab [Presence] in Serum
50
299
1.68
3.04
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
105
742
1.42
3.02
1.1
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
123
894
1.38
3.01
1.3
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
278
2261
1.24
2.96
2.7
1.5
mg/l
40.1
37.9
0.23
235
1799
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
72
1072
0.67
2.96
1.1
1.2
u/ml
58.5
45.8
—
5
121
(3037522) Nuclear Ab [Titer] in Serum
674
7634
0.87
2.93
1.3
1.3
titre
521.7
537.5
0.07
138
1711
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
32
170
1.89
2.89
2.9
2.5
%
34.4
42.0
—
7
68
(3034860) Kappa light chains.free [Mass/volume] in Serum
278
2269
1.23
2.88
2.7
1.5
mg/l
80.1
48.5
0.81
235
1812
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
114
1556
0.73
2.88
1.4
1.6
mg/l
3.6
3.8
0.09
94
1106
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
270
2197
1.24
2.88
2.7
1.5
ratio
1.4
2.1
1.13
17
180
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2698
25576
1.08
2.84
5.1
4.0
ug/l
3.3
2.5
1.12
2361
22789
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
52
321
1.62
2.82
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
226
2808
0.80
2.82
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
104
744
1.40
2.81
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
60
384
1.57
2.81
1.5
1.4
ml
1825.1
2010.5
0.43
19
94
(3022475) Manganese [Moles/volume] in Blood
8
18
4.45
2.79
1.9
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2497
23619
1.08
2.76
4.7
4.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
6
8.34
2.75
1.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
55
347
1.59
2.74
1.6
2.0
u/field
2.1
2.3
0.11
42
231
(21494434) Karyotype in Bone marrow
70
467
1.50
2.73
1.1
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
309
2566
1.21
2.72
2.3
1.4
g/l
3.3
3.1
2.11
231
1948
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
52
325
1.60
2.70
1.1
1.2
u/l
47.7
20.3
1.18
43
268
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
11
37
2.98
2.69
1.3
1.5
ml/s/173m2
0.5
0.8
—
5
22
(3006270) Folate [Moles/volume] in Blood
94
667
1.41
2.68
1.3
1.2
nmol/l
315.6
338.8
0.47
73
519
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
51
319
1.60
2.65
1.4
1.4
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
53
335
1.59
2.64
1.1
1.2
u/l
209.5
85.9
0.82
44
282
(3045414) Leukocytes [Presence] in Urine
343
2890
1.19
2.60
2.1
1.9
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
227
1835
1.24
2.60
3.2
3.2
nmol/l
0.8
0.8
0.09
176
1441
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
309
2580
1.21
2.59
2.2
1.4
g/l
10.1
10.3
0.31
253
2108
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
98
706
1.39
2.58
1.3
1.3
nmol/l
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
207
1658
1.25
2.58
2.5
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
99
1354
0.73
2.57
1.1
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
108
793
1.37
2.54
1.3
1.4
—
14.5
—
0
19
(3029937) Albumin [Presence] in Urine by Test strip
1819
17037
1.09
2.53
4.6
4.3
estimate
0.0
0.0
0.13
659
5076
(3042631) Mycobacterium sp identified in Specimen
114
845
1.35
2.53
2.3
3.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
43
261
1.65
2.52
1.1
1.3
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
17
75
2.27
2.50
1.5
1.3
u/l
30.0
489.2
0.49
12
47
(3017446) Testosterone [Moles/volume] in Serum or Plasma
393
3368
1.18
2.47
2.1
2.2
nmol/l
10.7
14.5
14.23
338
2902
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
21
102
2.06
2.46
2.0
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
280
3350
0.83
2.46
1.3
1.3
au/ml
43.6
51.7
0.31
17
142
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
608
5383
1.14
2.46
1.5
1.7
%
1.5
1.6
0.50
520
4547
(3019150) Specific gravity of Urine by Refractometry
1328
14327
0.91
2.45
4.6
4.4
kg/l
1.0
1.0
0.21
236
2203
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
382
1.52
2.44
1.4
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
14
58
2.42
2.36
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
315
3710
0.84
2.34
2.4
2.4
au/ml
23.1
26.3
0.16
12
128
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
71
2.26
2.33
1.9
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
108
806
1.34
2.32
1.2
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
60
0.00
2.24
0.0
1.8
—
18.0
—
0
60
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2062
21770
0.93
2.24
2.1
2.2
u/l
238.0
235.7
0.03
1940
20250
(3017569) Oxygen content in Arterial blood
54
358
1.51
2.23
2.3
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
156
1233
1.27
2.22
1.2
1.3
—
—
—
0
0
(44813793)
17
339
0.50
2.22
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
39
240
1.63
2.21
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
28
157
1.79
2.20
1.3
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
26
143
1.82
2.18
1.3
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
42
650
0.64
2.17
1.3
1.2
mmol/l
7.6
7.8
0.10
35
448
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
18
87
2.07
2.16
1.3
1.4
%
8.0
7.0
—
8
43
(4010399)
417
4771
0.87
2.16
1.4
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
68
476
1.43
2.16
3.0
3.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
94
696
1.35
2.15
1.3
1.4
u/ml
106.2
121.4
0.70
23
143
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
19
3.69
2.15
1.0
1.1
nmol/l
197.1
249.7
—
7
19
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
74
2.16
2.14
1.6
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
96
714
1.35
2.14
1.1
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
17
81
2.10
2.12
1.5
1.3
mmol/l
2.7
1.9
0.16
12
45
(3011397) Hemoglobin [Presence] in Urine by Test strip
1626
15269
1.08
2.11
3.7
3.9
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
8
25
3.20
2.09
1.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
54
364
1.49
2.08
1.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
62
430
1.44
2.08
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
61
867
0.70
2.06
3.8
4.3
umol/l
346.0
350.6
0.10
50
720
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
17
82
2.07
2.06
1.4
1.2
ug/l
39.2
131.0
—
9
50
(40765096) Chromosome analysis panel by Banding
17
82
2.07
2.06
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
136
1717
0.79
2.05
1.1
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
26
3.08
2.01
3.9
3.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
26
3.08
2.01
7.8
6.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
69
954
0.72
2.00
1.5
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
259
0.46
1.99
1.1
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
109
837
1.31
1.98
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
80
588
1.36
1.95
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
33
2.73
1.93
2.9
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
291
2492
1.17
1.92
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
54
372
1.45
1.90
1.4
1.5
umol/l
15.0
14.0
0.25
49
347
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
18
92
1.96
1.89
1.7
1.1
ug/l
2.9
2.7
0.07
13
68
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
23
396
0.58
1.89
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
55
381
1.45
1.88
1.2
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
23
395
0.58
1.87
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
23
395
0.58
1.87
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
357
0.56
1.87
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
21
369
0.57
1.86
1.2
1.4
pmol/l
105.4
153.9
—
6
100
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
11
46
2.39
1.85
1.1
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
94
1224
0.77
1.84
1.2
1.2
mmol/l
3.7
3.9
2.04
89
1138
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
23
392
0.59
1.83
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
23
392
0.59
1.83
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
255
2171
1.18
1.82
1.1
1.1
u/ml
9.6
1.3
—
9
34
(40759836) Histone Ab [Presence] in Serum by Immunoblot
23
391
0.59
1.81
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
86
648
1.33
1.81
1.7
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
97
744
1.31
1.80
1.2
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
60
2.17
1.77
2.2
1.9
e6/l
2456.3
154.1
—
8
37
(4094501)
144
1766
0.81
1.72
1.1
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
35
225
1.56
1.72
3.6
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
35
225
1.56
1.72
3.6
2.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
5045
49375
1.06
1.70
38.5
19.2
g/l
328.6
331.9
101.31
5006
48894
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
85
647
1.32
1.69
4.1
3.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
183
2186
0.83
1.68
1.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
163
1964
0.83
1.65
1.5
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
148
1800
0.82
1.65
1.7
1.5
e6/l
15976.4
14037.7
0.24
114
1298
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
90
697
1.29
1.59
1.2
1.2
u/ml
2.8
4.6
1.62
44
308
(3036312) Salmon IgE Ab [Units/volume] in Serum
6
20
3.00
1.58
1.2
1.0
u/ml
0.1
0.1
—
6
14
(3014051) Protein [Presence] in Urine by Test strip
181
1520
1.19
1.56
2.4
2.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
96
1215
0.79
1.55
1.4
1.4
e6/l
227.1
1100.4
2.45
80
1014
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
96
1213
0.79
1.54
1.4
1.3
e6/l
18.6
22.9
0.13
78
960
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
42
290
1.45
1.52
1.3
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
28
431
0.65
1.51
1.2
1.1
—
36.8
—
0
5
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
69
520
1.33
1.50
1.1
1.2
%
98.5
93.5
1.04
62
488
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
136
1116
1.22
1.49
2.8
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
151
1812
0.83
1.49
1.6
1.7
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
20
116
1.73
1.48
1.5
1.2
mmol/l
1.3
1.4
0.11
11
61
(3022621) pH of Urine by Test strip
491
4445
1.11
1.47
3.2
3.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
168
1410
1.20
1.47
3.4
2.6
mg/l
1.8
1.8
0.27
150
1229
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
840
9029
0.92
1.46
11.8
7.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
261
2273
1.15
1.46
2.5
1.5
g/l
1.1
0.5
1.54
214
1895
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1492
14160
1.07
1.44
3.1
2.8
ug/l
0.8
0.7
2.05
1068
9928
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
11
52
2.12
1.44
1.2
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
45
319
1.41
1.43
4.1
3.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
59
2.03
1.43
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
161
1911
0.84
1.43
1.5
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
129
1561
0.82
1.41
1.2
1.2
u/ml
35.9
48.2
—
7
94
(3045716) Anion gap in Serum or Plasma
48
347
1.39
1.37
2.4
2.1
mmol/l
9.3
9.2
0.08
34
257
(3044927) Protein electrophoresis panel - Urine
102
823
1.24
1.34
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
52
383
1.36
1.34
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
71
548
1.30
1.34
1.0
1.1
u/ml
5.6
3.6
0.23
27
192
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5979
60579
0.95
1.34
4.9
5.1
mmol/l
6.2
6.1
3.89
5375
54327
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
119
979
1.22
1.31
1.1
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
24
2.50
1.30
1.2
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
101
818
1.24
1.29
1.3
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
21
129
1.63
1.29
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
87
694
1.26
1.28
1.3
1.2
u/ml
287.9
292.1
0.04
55
434
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
229
2001
1.15
1.26
2.6
1.5
g/l
0.1
0.0
0.43
202
1794
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
122
1462
0.83
1.24
1.2
1.2
u/ml
3.0
5.3
1.65
23
243
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
212
1846
1.15
1.23
1.5
1.4
iu/ml
6.0
18.9
—
8
46
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
45
2.00
1.23
1.8
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
89
716
1.25
1.23
1.2
1.2
u/ml
5.0
4.3
0.12
36
231
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
121
1449
0.83
1.22
1.2
1.2
u/ml
5.6
6.7
0.12
15
156
(3022689) Creatine [Moles/volume] in Urine
12
215
0.56
1.22
1.4
1.3
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
11
56
1.97
1.21
1.2
1.2
mg/l
12.7
9.6
0.21
11
50
(3008536) Aspergillus sp Ab [Presence] in Serum
16
93
1.72
1.20
1.1
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
20
124
1.61
1.20
1.1
1.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
50
375
1.34
1.18
2.1
2.1
ug/min
23.3
193.1
—
7
95
(40768443) Skin Pathology biopsy report
285
2541
1.13
1.17
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
76
604
1.26
1.17
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
25
370
0.67
1.17
1.4
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
44
324
1.36
1.17
2.1
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
93
1134
0.82
1.15
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
243
2149
1.13
1.15
2.4
1.4
g/l
36.2
37.3
1.81
195
1774
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
83
670
1.24
1.13
1.1
1.2
%
115.4
115.1
0.03
73
600
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
267
2381
1.13
1.11
1.8
1.8
u/l
39.3
38.5
0.25
230
2009
(3004775) Volume in Urine collected for unspecified duration
78
627
1.25
1.11
2.4
2.3
ml
763.5
653.7
0.89
44
425
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
117
1389
0.84
1.10
1.6
1.8
nmol/l
40.0
44.6
1.65
111
1321
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
157
1352
1.16
1.09
1.1
1.1
u/ml
6.0
9.9
0.49
15
105
(3009871) Measles virus Ab [Titer] in Serum
7
138
0.51
1.09
1.4
1.7
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
32
2.19
1.08
1.9
2.2
—
—
—
0
0
(4268621)
61
478
1.28
1.07
2.2
2.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
291
0.65
1.07
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
31
219
1.42
1.06
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
24
161
1.49
1.06
1.7
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
106
886
1.20
1.05
2.1
2.2
mg/l
33.6
25.9
0.49
30
219
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
141
1638
0.86
1.04
1.4
1.5
g/l
0.2
0.2
0.02
133
1543
(3029075) Extractable nuclear Ab panel - Serum
8
147
0.54
1.03
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
146
1.51
1.02
1.0
1.1
—
—
—
0
0
(4027681)
14
227
0.62
1.02
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
52
403
1.29
1.01
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
14
83
1.69
1.01
1.1
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
145
1673
0.86
0.99
1.4
1.5
g/l
1.1
1.2
0.57
136
1574
(3002619) Bacteria identified in Specimen by Culture
18
115
1.57
0.99
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
87
1047
0.83
0.98
1.7
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
100
838
1.20
0.98
1.3
1.3
u/l
15.3
9.6
2.20
78
658
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
53
673
0.79
0.98
1.6
1.7
u/ml
21.2
24.9
0.33
12
156
(3014148) Varicella zoster virus Ab [Titer] in Serum
32
436
0.73
0.98
1.2
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
10
175
0.57
0.98
3.9
6.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
96
802
1.20
0.97
1.1
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
47
605
0.78
0.97
1.1
1.1
u/ml
0.5
1.4
1.73
14
239
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
145
1256
1.16
0.96
1.4
1.4
nmol/l
0.9
0.8
1.10
128
1037
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
12
199
0.60
0.96
6.7
11.9
mmol/l
0.8
0.7
0.46
12
182
(4211845)
46
354
1.30
0.95
4.0
3.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
113
1324
0.85
0.95
1.6
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
35
260
1.35
0.92
4.1
6.3
mmol/l
24.4
25.1
0.23
30
236
(3011288) Drugs identified in Urine by Screen method
31
419
0.74
0.92
1.3
2.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
38
498
0.76
0.91
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
51
401
1.27
0.91
1.1
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
17
111
1.53
0.87
1.8
1.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
16
103
1.55
0.87
2.2
1.8
%
33.4
26.8
0.65
16
96
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
15
95
1.58
0.87
2.4
2.8
u/field
0.9
0.5
0.50
15
95
(3016750) Collection duration of Urine
54
431
1.25
0.86
2.5
2.1
min
501.4
499.5
0.05
34
326
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
274
3008
0.91
0.86
1.1
1.2
iu/ml
127.0
131.5
0.06
76
1095
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
209
1875
1.12
0.85
2.5
1.5
g/l
0.0
0.0
0.69
182
1673
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
84
705
1.19
0.84
1.1
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
31
1.94
0.84
4.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
31
1.94
0.84
1.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
104
1.54
0.84
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
614
6517
0.94
0.84
1.3
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
318
1.29
0.83
2.6
2.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
39
501
0.78
0.83
1.0
1.1
u/ml
1.6
0.8
0.35
14
205
(3029634) Reagin Ab [Titer] in Serum by VDRL
49
611
0.80
0.82
1.8
1.9
—
4.1
—
0
12
(3029396) Erythrocyte agglutination [Presence] in Blood
6
32
1.88
0.81
2.3
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
105
1218
0.86
0.81
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
107
1237
0.86
0.80
1.3
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
84
710
1.18
0.79
3.3
3.0
mg/l
53.2
36.2
0.24
62
526
(3018001) Oat IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
0.3
—
0
12
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
24
0.00
0.79
0.0
5.2
—
365.8
—
0
24
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
115
1.48
0.76
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
22
157
1.40
0.76
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
430
4018
1.07
0.74
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
39
306
1.28
0.74
1.4
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
164
1466
1.12
0.74
1.8
1.9
mg/l
11.6
11.6
0.00
150
1348
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
750
7138
1.06
0.73
2.3
2.5
ug/l
4.7
7.6
6.50
619
6099
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
254
0.71
0.73
1.2
1.1
—
—
—
0
0
(4306422)
82
699
1.17
0.72
1.2
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
109
0.55
0.72
2.3
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
206
0.68
0.71
1.7
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
16
109
1.47
0.70
1.0
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
11
170
0.65
0.70
1.0
1.2
—
35.0
—
0
20
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
30
388
0.77
0.70
1.2
1.3
u/ml
0.2
1.0
1.90
18
202
(3005011) Chlamydia sp Ab [Titer] in Serum
9
58
1.55
0.69
1.6
1.8
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
13
193
0.67
0.69
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
13
193
0.67
0.69
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
13
193
0.67
0.69
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
13
193
0.67
0.69
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
13
85
1.53
0.68
1.8
2.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
135
1.41
0.68
1.0
1.1
%
86.2
86.2
—
10
70
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
42
1.67
0.68
1.1
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
59
1.53
0.68
1.3
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
69
1.59
0.68
1.1
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
104
909
1.15
0.68
1.2
1.3
iu/l
41.9
33.0
1.35
82
777
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
273
0.73
0.68
1.2
1.1
ratio
1.1
1.1
—
6
89
(3023419) Bacteria identified in Sputum by Culture
99
863
1.15
0.67
2.9
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2103
20512
1.03
0.67
4.4
3.9
%
22.3
24.3
8.19
1114
10281
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
47
572
0.82
0.66
1.3
1.3
titre
82.9
472.1
—
7
57
(3003888) Timothy IgE Ab [Units/volume] in Serum
42
517
0.81
0.66
1.0
1.1
u/ml
6.3
3.7
0.25
17
242
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
5
28
1.79
0.66
1.0
1.4
%
6.5
2.0
—
5
28
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
40
321
1.25
0.66
1.3
1.3
u/l
30.5
33.8
0.24
32
229
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
20
145
1.38
0.65
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
107
1213
0.88
0.64
1.1
1.2
u/ml
2.6
7.3
—
9
96
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
14
95
1.47
0.64
1.1
1.2
ng/l
129.4
144.6
—
5
66
(3020491) Glucose [Moles/volume] in Blood
38
470
0.81
0.63
1.5
2.3
mmol/l
7.8
7.0
0.65
29
320
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
292
0.75
0.63
1.2
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
249
2297
1.09
0.63
1.5
1.6
titre
285.5
309.9
0.04
11
116
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
36
287
1.26
0.63
1.4
1.4
nmol/l
0.2
0.2
0.45
24
219
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
212
0.71
0.63
1.3
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
13
87
1.49
0.63
1.8
2.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
78
902
0.86
0.63
1.2
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
89
1019
0.87
0.63
1.8
1.9
pmol/l
197.7
198.3
0.02
83
952
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
103
0.58
0.62
1.0
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
30
1.67
0.61
4.0
2.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
66
771
0.85
0.61
1.1
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
50
1.60
0.61
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
37
298
1.24
0.60
1.1
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
20
0.00
0.60
0.0
1.1
—
8.3
—
0
20
(3020874) Milk IgE Ab [Units/volume] in Serum
12
175
0.69
0.60
1.1
1.0
u/ml
0.7
1.5
—
5
60
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
16.2
—
0
6
(3007700) Barley IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.1
—
0
11
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
37.2
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
98
863
1.14
0.60
1.4
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
45
371
1.21
0.60
2.5
2.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
9.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
53
1.51
0.58
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
23
175
1.31
0.58
4.5
7.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
242
2609
0.93
0.57
1.2
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
314
2939
1.07
0.57
1.5
1.5
u/ml
16.7
17.5
—
9
73
(3026493) Urate [Moles/volume] in Serum or Plasma
1767
17241
1.03
0.56
2.9
2.5
umol/l
5029.5
6316.7
0.60
1533
14502
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
110
1228
0.89
0.55
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5576
56208
0.97
0.54
4.5
4.7
mu/l
3.1
2.0
0.91
4936
50448
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
122
0.66
0.54
1.3
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
82
1.46
0.54
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
37
449
0.82
0.54
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
156
1707
0.91
0.53
1.5
1.6
iu/ml
3.7
3.8
0.01
33
394
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
42
502
0.84
0.53
1.7
1.7
—
1777.8
—
0
18
(3028433) Virus identified in Specimen by Culture
23
178
1.29
0.52
1.1
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
199
1839
1.08
0.52
2.6
1.5
g/l
0.0
0.0
0.00
181
1667
(3040151) Glucose [Moles/volume] in Capillary blood
94
836
1.13
0.52
10.0
15.5
mmol/l
7.3
7.4
0.17
81
680
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
36
296
1.22
0.51
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
54
627
0.86
0.49
1.3
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
34
279
1.22
0.49
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
190
0.74
0.49
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
873
8440
1.04
0.48
4.3
5.0
%
32.9
33.2
0.23
562
5585
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
17
223
0.76
0.48
1.1
1.1
—
466.0
—
0
59
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
47
550
0.85
0.48
1.1
1.1
—
1.9
—
0
7
(40761535) Cells panel - Urine sediment
571
5950
0.96
0.47
3.9
3.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
58
665
0.87
0.46
1.4
1.7
—
—
—
0
0
(4024509)
79
702
1.13
0.46
1.6
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
85
759
1.12
0.46
1.1
1.3
pmol/l
413.4
271.7
0.46
69
567
(3011985) Renin [Units/volume] in Plasma
90
807
1.12
0.45
1.3
1.3
mu/l
103.6
60.4
0.54
80
714
(3025130) Human papilloma virus identified in Specimen
45
384
1.17
0.45
1.3
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
187
2010
0.93
0.45
1.5
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
292
1.20
0.45
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
69
779
0.88
0.44
1.1
1.2
miu/ml
144.2
217.1
1.30
24
298
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
112
1.34
0.44
1.6
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
32
384
0.83
0.44
1.0
1.1
u/ml
5.7
2.8
—
8
157
(3044290) Cell count panel - Cerebral spinal fluid
97
1073
0.90
0.44
1.3
1.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
10
69
1.45
0.44
8.1
5.0
ug/min
51.5
43.2
—
10
55
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
197
0.76
0.44
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
40
339
1.18
0.44
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
208
0.77
0.43
1.3
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
59
671
0.88
0.43
1.1
1.1
au/ml
8.8
16.5
—
5
23
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
78
1.41
0.43
1.3
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
40
340
1.18
0.42
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
30
248
1.21
0.42
1.5
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2255
22171
1.02
0.42
3.2
3.2
mmol/l
7.4
7.3
1.00
1878
18375
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
87
1.38
0.42
1.1
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
38
446
0.85
0.42
1.3
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
8
57
1.40
0.42
1.6
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
21
167
1.26
0.41
1.3
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
4.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
15
0.00
0.41
0.0
8.9
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
0
17
0.00
0.40
0.0
7.9
—
44.5
—
0
8
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
79
1.39
0.40
1.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
15
194
0.77
0.40
1.3
1.2
g/l
—
0.2
—
0
11
(4212803)
8
60
1.33
0.40
1.1
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
29
347
0.83
0.40
1.9
1.4
u/l
4.7
6.1
2.30
23
289
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
18
227
0.79
0.40
1.3
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
47
538
0.87
0.39
2.0
2.0
ug/l
2.0
2.2
0.31
41
446
(3003129) Base excess in Capillary blood by calculation
24
196
1.22
0.39
1.8
1.6
mmol/l
-0.2
0.6
0.54
24
187
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
30
251
1.20
0.39
1.3
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
26
313
0.83
0.38
1.4
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
160
1.25
0.38
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
67
1.34
0.38
3.8
4.2
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
13
98
1.33
0.37
3.1
1.2
%
109.5
107.1
0.07
13
93
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
70
1.29
0.36
1.1
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
650
0.89
0.36
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
32
272
1.18
0.36
1.2
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
59
659
0.89
0.35
1.4
1.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
41
469
0.87
0.35
1.1
1.2
titre
98.0
158.4
—
5
83
(40768446) Kidney Pathology biopsy report
23
190
1.21
0.34
1.5
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
276
0.83
0.34
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
65
585
1.11
0.34
1.2
1.4
mosm/kgh2o
273.3
276.8
0.54
49
435
(3036525) Urea [Moles/time] in 24 hour Urine
6
45
1.33
0.33
3.3
3.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
133
0.75
0.33
1.6
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
59
656
0.90
0.33
1.4
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
103
1113
0.92
0.32
1.3
1.4
—
—
—
0
0
(4015189)
18
220
0.82
0.32
2.2
2.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
47
1.28
0.32
1.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
47
1.28
0.32
1.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
132
0.76
0.32
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
17
137
1.24
0.32
1.9
2.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
47
527
0.89
0.31
1.1
1.1
—
48.8
—
0
11
(3020191) Ethanol [Moles/volume] in Serum or Plasma
48
428
1.12
0.30
1.1
1.3
promille
1.1
1.2
0.15
35
320
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
17
138
1.23
0.30
1.1
1.1
%
79.8
85.5
—
8
68
(1001926) Buprenorphine [Presence] in Urine by Screen method
45
505
0.89
0.30
1.4
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
1.6
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
152
0.79
0.29
1.5
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
54
488
1.11
0.28
1.5
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
2208
21806
1.02
0.28
3.2
3.2
mg/l
290.9
317.5
0.13
1481
13853
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
21
248
0.85
0.28
3.0
2.1
umol/l
54.3
59.0
0.39
21
196
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
116
0.78
0.27
1.4
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
26
224
1.16
0.27
1.4
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
26
224
1.16
0.27
1.8
1.9
ug/l
57.2
49.5
0.52
26
217
(3020961) Endomysium IgA Ab [Titer] in Serum
224
2341
0.96
0.27
1.1
1.1
titre
163.8
198.6
—
8
55
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
66
1.21
0.26
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
149
0.80
0.25
1.3
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
152
1602
0.95
0.25
1.6
1.7
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
9
72
1.25
0.25
4.3
2.5
—
30.4
—
0
14
(4146454)
91
849
1.07
0.25
2.5
2.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
64
695
0.92
0.25
1.7
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
60
550
1.09
0.25
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
494
5074
0.97
0.24
1.4
1.5
—
—
—
0
0
(44806420)
28
245
1.14
0.24
2.4
2.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
191
0.84
0.24
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
137
0.80
0.24
1.3
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
78
1.28
0.24
2.1
1.7
umol/l
47.7
44.8
—
10
78
(3007916) DNA double strand Ab [Titer] in Serum
6
83
0.72
0.24
1.0
1.2
—
87.0
—
0
6
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
6
84
0.71
0.24
1.2
1.5
mu/l
5378.2
719.9
—
6
77
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
6
85
0.71
0.24
1.2
1.5
%
72.2
71.5
—
6
78
(3037692) Legionella sp identified in Specimen by Organism specific culture
21
180
1.17
0.23
1.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
13
158
0.82
0.23
1.5
1.5
ug/l
12.1
9.2
0.69
13
158
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
152
1.18
0.23
4.2
7.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
147
0.82
0.23
1.1
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
91
0.77
0.22
8.0
11.6
mmol/l
7.9
5.1
—
7
91
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
231
0.87
0.21
1.1
1.1
u/l
2.9
1.1
—
9
103
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
1370.0
—
0
11
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
19
163
1.17
0.21
2.6
2.6
mmol/l
7.3
7.8
0.24
11
104
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
145
0.83
0.21
1.6
1.6
ng/l
171.4
111.9
0.41
12
145
(3006653) Thiamine [Moles/volume] in Blood
32
287
1.12
0.20
1.0
1.1
nmol/l
132.6
137.9
0.17
32
287
(3027944) Amphetamines [Presence] in Urine
60
646
0.93
0.20
1.4
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
57
615
0.93
0.20
1.4
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
145
1.17
0.20
1.1
1.4
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
19
164
1.16
0.20
1.1
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
208
0.86
0.20
1.2
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
50
1.20
0.19
1.0
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
39
427
0.91
0.19
1.2
1.2
mmol/l
11.6
11.7
0.03
15
118
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
38
346
1.10
0.19
4.0
4.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
11
90
1.22
0.19
2.5
2.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
196
0.87
0.18
1.8
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
156
1.15
0.18
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
49
454
1.08
0.18
1.1
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
60
1.17
0.17
1.6
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
60
1.17
0.17
1.1
1.2
umol/24h
1.6
1.7
—
7
60
(3020682) Albumin/Creatinine [Ratio] in Urine
2328
23094
1.01
0.17
4.0
4.0
mg/mmol
10.4
9.3
0.47
1530
14590
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
17
194
0.88
0.16
1.1
1.1
%
97.8
94.1
0.15
12
150
(3027923) C peptide [Moles/volume] in Serum or Plasma
39
359
1.09
0.16
1.3
1.3
nmol/l
1.2
1.2
0.01
29
272
(3002523) Influenza virus A Ag [Presence] in Specimen
49
456
1.07
0.16
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
317
3092
1.03
0.16
2.9
2.9
pmol/l
4.3
4.4
1.56
277
2663
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
139
1.15
0.16
1.1
1.2
umol/24h
0.7
0.6
—
8
60
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
72
1.11
0.16
9.1
10.7
—
—
—
0
0
(3024471) HLA-A [Type]
11
130
0.85
0.16
1.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
235
0.89
0.16
1.9
2.0
umol/l
104.7
133.1
0.36
12
130
(40757373) Influenza virus identified in Isolate
12
140
0.86
0.15
1.2
1.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
21
234
0.90
0.15
5.0
5.5
%
60.2
71.6
0.91
14
197
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
66
697
0.95
0.15
1.6
1.5
%
27.1
28.4
0.11
43
450
(3035933) Granulocytes/100 leukocytes in Blood
9
82
1.10
0.15
1.2
1.8
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
83
1.08
0.14
2.8
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
607
5975
1.02
0.14
1.3
1.4
—
—
—
0
0
(4062490)
52
552
0.94
0.14
1.2
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
96
0.83
0.13
1.3
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
103
1.17
0.13
1.0
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
32
345
0.93
0.13
1.6
1.5
%
0.8
4.3
—
9
78
(3016018) Differential panel - Cerebral spinal fluid
57
540
1.06
0.12
1.4
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
127
0.87
0.12
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
158
1535
1.03
0.12
3.8
3.6
mg/l
33.1
27.6
0.95
100
1019
(3017704) Immunofixation for Urine
41
385
1.07
0.12
1.5
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
84
874
0.96
0.11
1.7
1.7
—
—
—
0
0
(4133840)
14
124
1.13
0.11
1.2
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
45
426
1.06
0.10
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
146
0.89
0.10
2.4
5.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
17
154
1.10
0.10
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
38
402
0.94
0.10
17.8
10.9
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
46
1.09
0.09
1.6
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
46
1.09
0.09
1.6
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
46
1.09
0.09
1.6
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
10
113
0.88
0.08
1.0
1.2
—
320.0
—
0
5
(3027135) IgG subclass 1 [Mass/volume] in Serum
53
552
0.96
0.08
1.2
1.4
g/l
7.2
6.8
0.35
39
380
(3028192) IgG subclass 2 [Mass/volume] in Serum
53
552
0.96
0.08
1.2
1.4
g/l
3.0
3.0
0.08
39
378
(3024139) IgG subclass 3 [Mass/volume] in Serum
53
552
0.96
0.08
1.2
1.4
g/l
0.5
0.4
0.26
38
384
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
123
0.89
0.08
1.2
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
82
845
0.97
0.08
1.1
1.1
iu/ml
11376.7
1216.2
0.41
16
173
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
72
0.83
0.07
1.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
72
0.83
0.07
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
174
0.92
0.07
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
81
0.86
0.07
1.1
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
102
0.88
0.06
1.2
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
110
1078
1.02
0.06
1.2
1.2
u/l
38.1
28.0
0.62
97
915
(3004616) Nuclear Ab [Presence] in Serum
75
767
0.98
0.05
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
352
0.97
0.04
1.6
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
195
1929
1.01
0.04
2.5
2.3
ug/min
129.9
111.0
0.20
109
1135
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
20
190
1.05
0.04
1.1
1.1
miu/ml
1787.4
1745.7
0.05
20
190
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
121
1.07
0.03
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
139
0.93
0.03
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
24
250
0.96
0.03
1.2
1.2
g/l
39.4
39.9
0.05
14
126
(3010144) Erythrocytes [#/volume] in Synovial fluid
72
707
1.02
0.03
1.6
1.3
e6/l
122753.5
194793.1
0.39
47
496
(3023430) Cat dander IgE Ab [Units/volume] in Serum
34
350
0.97
0.03
1.0
1.1
u/ml
6.1
2.4
—
9
140
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
34
350
0.97
0.03
1.2
1.1
nmol/l
2.6
7.7
1.06
13
74
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
94
927
1.01
0.03
1.7
1.5
%
63.5
61.8
0.16
64
593
(3024263) Appearance of Synovial fluid
38
370
1.03
0.02
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
158
0.95
0.02
1.7
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
18
172
1.05
0.02
1.2
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
123
1241
0.99
0.02
1.6
1.7
iu/l
6.9
4.6
0.54
29
387
(3034988) Calcium [Moles/volume] in Capillary blood
13
137
0.95
0.01
1.5
1.9
mmol/l
1.2
1.2
0.10
13
132
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
17
177
0.96
0.01
1.2
1.3
nmol/l
91.3
155.0
2.06
12
125
(3034426) Prothrombin time (PT)
18
173
1.04
0.01
1.2
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
20
207
0.97
0.01
1.3
1.5
ug/l
5.0
8.2
2.42
20
182
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
22
227
0.97
0.01
2.5
2.7
umol/l
32.4
28.8
0.78
12
168
(3001186) Copper [Moles/volume] in Serum or Plasma
11
116
0.95
0.01
1.2
1.1
umol/l
17.5
16.3
0.68
11
108
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
12
126
0.95
0.00
3.8
7.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
185
0.97
0.00
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
185
0.97
0.00
1.4
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
17
167
1.02
0.00
1.2
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
84
845
0.99
0.00
1.5
1.6
g/l
1.0
0.8
0.53
62
632
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
118
1.02
0.00
1.3
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
39
385
1.01
0.00
2.3
1.9
umol/l
22.0
15.6
—
7
39
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
184
0.98
0.00
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
184
0.98
0.00
1.4
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
12
119
1.01
0.00
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
152
0.99
0.00
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
153
0.98
0.00
1.5
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
25
252
0.99
0.00
1.1
1.2
—
—
—
0
0
(4198724)
11
112
0.98
0.00
1.4
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
14
135
1.04
0.00
1.2
1.4
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
2.2
1.6
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
121.4
—
0
5
(3007147) Virus identified in Stool by Electron microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.3
—
0.2
—
0
7
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
343.6
—
0
5
(3025504) Homovanillate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
11.3
—
0
7
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
8
0.00
0.00
0.0
4.6
—
65.9
—
0
8
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
35.6
—
0
9
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
1.8
—
0
9
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
69
1.01
0.00
1.4
1.7
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
71
0.99
0.00
1.4
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
131.0
—
0
6
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
7
69
1.01
0.00
1.3
1.6
mmol/l
1.5
2.8
—
7
60
(3013293) Extractable nuclear Ab [Presence] in Serum
8
83
0.96
0.00
1.0
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
53
0.94
0.00
1.6
1.1
u/ml
47.3
56.8
—
5
53
(3016135) IgD [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
181.6
—
0
9
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_COLON_EXALLC – Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

GWS hits: 17

This endpoint is excluded (different definition than used in FinnGen).